| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | CD8 receptor binding | 2.94e-12 | 9 | 117 | 6 | GO:0042610 | |
| GeneOntologyMolecularFunction | TAP complex binding | 2.94e-12 | 9 | 117 | 6 | GO:0062061 | |
| GeneOntologyMolecularFunction | TAP1 binding | 7.32e-12 | 10 | 117 | 6 | GO:0046978 | |
| GeneOntologyMolecularFunction | TAP2 binding | 7.32e-12 | 10 | 117 | 6 | GO:0046979 | |
| GeneOntologyMolecularFunction | TAP binding | 7.32e-12 | 10 | 117 | 6 | GO:0046977 | |
| GeneOntologyMolecularFunction | beta-2-microglobulin binding | 3.19e-11 | 12 | 117 | 6 | GO:0030881 | |
| GeneOntologyMolecularFunction | natural killer cell lectin-like receptor binding | 4.17e-10 | 17 | 117 | 6 | GO:0046703 | |
| GeneOntologyMolecularFunction | T cell receptor binding | 1.29e-09 | 20 | 117 | 6 | GO:0042608 | |
| GeneOntologyMolecularFunction | MHC class I protein binding | 2.85e-08 | 32 | 117 | 6 | GO:0042288 | |
| GeneOntologyMolecularFunction | 14-3-3 protein binding | 1.57e-07 | 42 | 117 | 6 | GO:0071889 | |
| GeneOntologyMolecularFunction | peptide antigen binding | 4.05e-07 | 49 | 117 | 6 | GO:0042605 | |
| GeneOntologyMolecularFunction | MHC protein binding | 1.12e-06 | 58 | 117 | 6 | GO:0042287 | |
| GeneOntologyMolecularFunction | glutamate-gated calcium ion channel activity | 1.07e-05 | 8 | 117 | 3 | GO:0022849 | |
| GeneOntologyMolecularFunction | NMDA glutamate receptor activity | 1.07e-05 | 8 | 117 | 3 | GO:0004972 | |
| GeneOntologyMolecularFunction | peptide binding | 1.08e-04 | 318 | 117 | 9 | GO:0042277 | |
| GeneOntologyMolecularFunction | glutamate-gated receptor activity | 1.26e-04 | 17 | 117 | 3 | GO:0004970 | |
| GeneOntologyMolecularFunction | non-membrane spanning protein tyrosine kinase activity | 1.51e-04 | 46 | 117 | 4 | GO:0004715 | |
| GeneOntologyMolecularFunction | phosphopyruvate hydratase activity | 2.03e-04 | 4 | 117 | 2 | GO:0004634 | |
| GeneOntologyMolecularFunction | calcium ion transmembrane transporter activity | 2.66e-04 | 151 | 117 | 6 | GO:0015085 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | 2.71e-04 | 441 | 117 | 10 | GO:0016887 | |
| GeneOntologyMolecularFunction | protein-folding chaperone binding | 3.75e-04 | 161 | 117 | 6 | GO:0051087 | |
| GeneOntologyMolecularFunction | glutamate receptor activity | 5.18e-04 | 27 | 117 | 3 | GO:0008066 | |
| GeneOntologyMolecularFunction | ligand-gated calcium channel activity | 7.82e-04 | 31 | 117 | 3 | GO:0099604 | |
| GeneOntologyMolecularFunction | antigen binding | 8.95e-04 | 190 | 117 | 6 | GO:0003823 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | ABCA13 DDX60 WRN MCM5 IDE KATNA1 HELZ KIF3C ATP2A2 ATP2A3 AFG1L | 9.69e-04 | 614 | 117 | 11 | GO:0140657 |
| GeneOntologyMolecularFunction | potassium:chloride symporter activity | 1.19e-03 | 9 | 117 | 2 | GO:0015379 | |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | SLC12A6 CACHD1 GRIN2A GRIN2C GRIN2D SLC9C1 SLC12A9 ATP2A2 ATP2A3 | 1.67e-03 | 465 | 117 | 9 | GO:0046873 |
| GeneOntologyMolecularFunction | P-type calcium transporter activity | 1.81e-03 | 11 | 117 | 2 | GO:0005388 | |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | ABCA13 DDX60 WRN MCM5 IDE KATNA1 KIF3C GNAO1 GNAT2 ATP2A2 ATP2A3 AFG1L | 1.98e-03 | 775 | 117 | 12 | GO:0017111 |
| GeneOntologyMolecularFunction | profilin binding | 2.55e-03 | 13 | 117 | 2 | GO:0005522 | |
| GeneOntologyMolecularFunction | glutamate binding | 2.96e-03 | 14 | 117 | 2 | GO:0016595 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-dependent | 7.70e-13 | 8 | 116 | 6 | GO:0002485 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of endogenous peptide antigen via MHC class I | 3.37e-11 | 23 | 116 | 7 | GO:0019885 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of endogenous peptide antigen | 6.55e-11 | 25 | 116 | 7 | GO:0002483 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-independent | 2.12e-10 | 16 | 116 | 6 | GO:0002486 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway | 3.27e-10 | 17 | 116 | 6 | GO:0002484 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of endogenous peptide antigen via MHC class Ib | 3.27e-10 | 17 | 116 | 6 | GO:0002476 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of endogenous antigen | 4.44e-10 | 32 | 116 | 7 | GO:0019883 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of peptide antigen via MHC class Ib | 4.88e-10 | 18 | 116 | 6 | GO:0002428 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of exogenous peptide antigen via MHC class I | 4.88e-10 | 18 | 116 | 6 | GO:0042590 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of peptide antigen via MHC class I | 2.84e-09 | 41 | 116 | 7 | GO:0002474 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation via MHC class Ib | 4.51e-09 | 25 | 116 | 6 | GO:0002475 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of exogenous peptide antigen | 9.02e-09 | 48 | 116 | 7 | GO:0002478 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of peptide antigen | 1.08e-08 | 76 | 116 | 8 | GO:0048002 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of exogenous antigen | 3.52e-08 | 58 | 116 | 7 | GO:0019884 | |
| GeneOntologyBiologicalProcess | protection from natural killer cell mediated cytotoxicity | 1.17e-07 | 9 | 116 | 4 | GO:0042270 | |
| GeneOntologyBiologicalProcess | positive regulation of T cell mediated cytotoxicity | 1.24e-07 | 42 | 116 | 6 | GO:0001916 | |
| GeneOntologyBiologicalProcess | regulation of T cell mediated cytotoxicity | 5.14e-07 | 53 | 116 | 6 | GO:0001914 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation | 1.20e-06 | 139 | 116 | 8 | GO:0019882 | |
| GeneOntologyBiologicalProcess | regulation of cell projection organization | HLA-A HLA-B HLA-C HLA-E HLA-G HLA-H PLXND1 DBN1 KATNA1 ZNF804A IL1RAPL1 IFT88 PTPRZ1 FUT9 KIF3C CTTN TACSTD2 CNTN1 | 1.53e-06 | 863 | 116 | 18 | GO:0031344 |
| GeneOntologyBiologicalProcess | regulation of neuron projection development | HLA-A HLA-B HLA-C HLA-E HLA-G HLA-H PLXND1 DBN1 KATNA1 ZNF804A IL1RAPL1 PTPRZ1 FUT9 KIF3C CNTN1 | 1.77e-06 | 612 | 116 | 15 | GO:0010975 |
| GeneOntologyBiologicalProcess | T cell mediated cytotoxicity | 2.72e-06 | 70 | 116 | 6 | GO:0001913 | |
| GeneOntologyBiologicalProcess | positive regulation of T cell mediated immunity | 3.77e-06 | 74 | 116 | 6 | GO:0002711 | |
| GeneOntologyBiologicalProcess | regulation of plasma membrane bounded cell projection organization | HLA-A HLA-B HLA-C HLA-E HLA-G HLA-H PLXND1 DBN1 KATNA1 ZNF804A IL1RAPL1 IFT88 PTPRZ1 FUT9 KIF3C TACSTD2 CNTN1 | 5.07e-06 | 846 | 116 | 17 | GO:0120035 |
| GeneOntologyBiologicalProcess | negative regulation of neuron projection development | 5.16e-06 | 169 | 116 | 8 | GO:0010977 | |
| GeneOntologyBiologicalProcess | positive regulation of leukocyte mediated cytotoxicity | 5.53e-06 | 79 | 116 | 6 | GO:0001912 | |
| GeneOntologyBiologicalProcess | negative regulation of cell projection organization | 6.86e-06 | 233 | 116 | 9 | GO:0031345 | |
| GeneOntologyBiologicalProcess | positive regulation of cell killing | 1.03e-05 | 88 | 116 | 6 | GO:0031343 | |
| GeneOntologyBiologicalProcess | neuron projection development | HLA-A HLA-B HLA-C CNTNAP1 HLA-E HLA-G HLA-H PLXND1 ADGRV1 DBN1 KATNA1 ZNF804A IL1RAPL1 IFT88 PTPRZ1 ITSN2 FUT9 KIF3C CTTN CNTN1 | 3.02e-05 | 1285 | 116 | 20 | GO:0031175 |
| GeneOntologyBiologicalProcess | calcium ion transport from cytosol to endoplasmic reticulum | 3.14e-05 | 2 | 116 | 2 | GO:1903515 | |
| GeneOntologyBiologicalProcess | regulation of T cell mediated immunity | 3.89e-05 | 111 | 116 | 6 | GO:0002709 | |
| GeneOntologyBiologicalProcess | neuron development | HLA-A HLA-B HLA-C CNTNAP1 HLA-E HLA-G HLA-H PLXND1 ADGRV1 DBN1 KATNA1 ZNF804A IL1RAPL1 IFT88 PTPRZ1 ITSN2 FUT9 KIF3C GNAT2 CTTN CNTN1 | 6.08e-05 | 1463 | 116 | 21 | GO:0048666 |
| GeneOntologyBiologicalProcess | regulation of leukocyte mediated cytotoxicity | 7.23e-05 | 124 | 116 | 6 | GO:0001910 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell mediated cytotoxicity | 7.42e-05 | 40 | 116 | 4 | GO:0045953 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell mediated immunity | 8.19e-05 | 41 | 116 | 4 | GO:0002716 | |
| GeneOntologyBiologicalProcess | startle response | 8.19e-05 | 41 | 116 | 4 | GO:0001964 | |
| GeneOntologyBiologicalProcess | multicellular organism growth | 8.34e-05 | 249 | 116 | 8 | GO:0035264 | |
| GeneOntologyBiologicalProcess | excitatory chemical synaptic transmission | 9.20e-05 | 16 | 116 | 3 | GO:0098976 | |
| GeneOntologyBiologicalProcess | inner ear development | 9.32e-05 | 253 | 116 | 8 | GO:0048839 | |
| GeneOntologyBiologicalProcess | positive regulation of excitatory postsynaptic potential | 9.89e-05 | 43 | 116 | 4 | GO:2000463 | |
| GeneOntologyBiologicalProcess | negative regulation of leukocyte mediated cytotoxicity | 1.41e-04 | 47 | 116 | 4 | GO:0001911 | |
| GeneOntologyBiologicalProcess | regulation of cell killing | 1.84e-04 | 147 | 116 | 6 | GO:0031341 | |
| GeneOntologyBiologicalProcess | directional locomotion | 1.87e-04 | 4 | 116 | 2 | GO:0033058 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway | 1.87e-04 | 4 | 116 | 2 | GO:0002488 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway, TAP-dependent | 1.87e-04 | 4 | 116 | 2 | GO:0002489 | |
| GeneOntologyBiologicalProcess | positive regulation of lymphocyte mediated immunity | 2.06e-04 | 150 | 116 | 6 | GO:0002708 | |
| GeneOntologyBiologicalProcess | positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | 2.06e-04 | 150 | 116 | 6 | GO:0002824 | |
| GeneOntologyBiologicalProcess | negative regulation of cell killing | 2.09e-04 | 52 | 116 | 4 | GO:0031342 | |
| GeneOntologyBiologicalProcess | ear development | 2.11e-04 | 285 | 116 | 8 | GO:0043583 | |
| GeneOntologyBiologicalProcess | response to gamma radiation | 2.78e-04 | 56 | 116 | 4 | GO:0010332 | |
| GeneOntologyBiologicalProcess | positive regulation of adaptive immune response | 2.82e-04 | 159 | 116 | 6 | GO:0002821 | |
| GeneOntologyBiologicalProcess | somatic recombination of T cell receptor gene segments | 3.10e-04 | 5 | 116 | 2 | GO:0002681 | |
| GeneOntologyBiologicalProcess | positive regulation of CD8-positive, alpha-beta T cell proliferation | 3.10e-04 | 5 | 116 | 2 | GO:2000566 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of exogenous protein antigen via MHC class Ib, TAP-dependent | 3.10e-04 | 5 | 116 | 2 | GO:0002481 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of exogenous peptide antigen via MHC class Ib | 3.10e-04 | 5 | 116 | 2 | GO:0002477 | |
| GeneOntologyBiologicalProcess | T cell receptor V(D)J recombination | 3.10e-04 | 5 | 116 | 2 | GO:0033153 | |
| GeneOntologyBiologicalProcess | cytosol to endoplasmic reticulum transport | 3.10e-04 | 5 | 116 | 2 | GO:0046967 | |
| GeneOntologyBiologicalProcess | somatic diversification of T cell receptor genes | 3.10e-04 | 5 | 116 | 2 | GO:0002568 | |
| GeneOntologyBiologicalProcess | T cell mediated immunity | 3.22e-04 | 163 | 116 | 6 | GO:0002456 | |
| GeneOntologyBiologicalProcess | negative regulation of cellular component organization | HLA-A HLA-B HLA-C HLA-E HLA-G HLA-H DBN1 KATNA1 AR MAPRE1 PFN4 PTPRZ1 MID1 TACSTD2 | 3.54e-04 | 864 | 116 | 14 | GO:0051129 |
| GeneOntologyBiologicalProcess | ionotropic glutamate receptor signaling pathway | 4.59e-04 | 27 | 116 | 3 | GO:0035235 | |
| GeneOntologyBiologicalProcess | positive regulation of leukocyte mediated immunity | 4.70e-04 | 175 | 116 | 6 | GO:0002705 | |
| GeneOntologyBiologicalProcess | dendritic spine organization | 4.84e-04 | 115 | 116 | 5 | GO:0097061 | |
| GeneOntologyBiologicalProcess | modulation of excitatory postsynaptic potential | 4.94e-04 | 65 | 116 | 4 | GO:0098815 | |
| GeneOntologyBiologicalProcess | positive regulation of neuron projection development | 5.24e-04 | 249 | 116 | 7 | GO:0010976 | |
| GeneOntologyBiologicalProcess | leukocyte mediated cytotoxicity | 6.66e-04 | 187 | 116 | 6 | GO:0001909 | |
| GeneOntologyBiologicalProcess | positive regulation of alpha-beta T cell proliferation | 6.95e-04 | 31 | 116 | 3 | GO:0046641 | |
| GeneOntologyBiologicalProcess | neuron projection organization | 7.60e-04 | 127 | 116 | 5 | GO:0106027 | |
| GeneOntologyBiologicalProcess | regulation of natural killer cell mediated cytotoxicity | 8.92e-04 | 76 | 116 | 4 | GO:0042269 | |
| GeneOntologyBiologicalProcess | tolerance induction | 9.95e-04 | 35 | 116 | 3 | GO:0002507 | |
| GeneOntologyBiologicalProcess | regulation of natural killer cell mediated immunity | 1.08e-03 | 80 | 116 | 4 | GO:0002715 | |
| GeneOntologyBiologicalProcess | regulation of neuronal synaptic plasticity | 1.24e-03 | 83 | 116 | 4 | GO:0048168 | |
| GeneOntologyBiologicalProcess | negative regulation of lymphocyte mediated immunity | 1.24e-03 | 83 | 116 | 4 | GO:0002707 | |
| GeneOntologyBiologicalProcess | regulation of CD8-positive, alpha-beta T cell proliferation | 1.37e-03 | 10 | 116 | 2 | GO:2000564 | |
| GeneOntologyBiologicalProcess | immunoglobulin V(D)J recombination | 1.37e-03 | 10 | 116 | 2 | GO:0033152 | |
| GeneOntologyBiologicalProcess | positive regulation of CD8-positive, alpha-beta T cell activation | 1.37e-03 | 10 | 116 | 2 | GO:2001187 | |
| GeneOntologyCellularComponent | MHC class Ib protein complex | 1.79e-13 | 7 | 116 | 6 | GO:0032398 | |
| GeneOntologyCellularComponent | MHC class I protein complex | 5.28e-12 | 10 | 116 | 6 | GO:0042612 | |
| GeneOntologyCellularComponent | MHC class I peptide loading complex | 7.42e-11 | 14 | 116 | 6 | GO:0042824 | |
| GeneOntologyCellularComponent | cis-Golgi network membrane | 3.02e-10 | 17 | 116 | 6 | GO:0033106 | |
| GeneOntologyCellularComponent | Golgi medial cisterna | 2.40e-09 | 23 | 116 | 6 | GO:0005797 | |
| GeneOntologyCellularComponent | MHC protein complex | 5.39e-09 | 26 | 116 | 6 | GO:0042611 | |
| GeneOntologyCellularComponent | lumenal side of endoplasmic reticulum membrane | 3.65e-08 | 35 | 116 | 6 | GO:0098553 | |
| GeneOntologyCellularComponent | ER to Golgi transport vesicle membrane | 6.46e-08 | 64 | 116 | 7 | GO:0012507 | |
| GeneOntologyCellularComponent | endoplasmic reticulum exit site | 1.14e-07 | 42 | 116 | 6 | GO:0070971 | |
| GeneOntologyCellularComponent | lumenal side of membrane | 2.60e-07 | 48 | 116 | 6 | GO:0098576 | |
| GeneOntologyCellularComponent | COPII-coated ER to Golgi transport vesicle | 2.68e-06 | 110 | 116 | 7 | GO:0030134 | |
| GeneOntologyCellularComponent | recycling endosome membrane | 3.02e-06 | 112 | 116 | 7 | GO:0055038 | |
| GeneOntologyCellularComponent | synaptic membrane | GRIN2A GRIN2C GRIN2D DBN1 GPR179 IL1RAPL1 PTPRZ1 ITSN2 GNAO1 ENO2 SLC16A7 CDH9 EPB41L1 CNTN1 | 4.38e-06 | 583 | 116 | 14 | GO:0097060 |
| GeneOntologyCellularComponent | phagocytic vesicle membrane | 6.83e-06 | 83 | 116 | 6 | GO:0030670 | |
| GeneOntologyCellularComponent | plasma membrane protein complex | HLA-A HLA-B HLA-C HLA-E HLA-G HLA-H CACHD1 GRIN2A GRIN2C GRIN2D TF ZAP70 GNAO1 GNAT2 CTTN CDH9 | 7.01e-06 | 785 | 116 | 16 | GO:0098797 |
| GeneOntologyCellularComponent | cis-Golgi network | 7.85e-06 | 85 | 116 | 6 | GO:0005801 | |
| GeneOntologyCellularComponent | Golgi cisterna | 1.04e-05 | 135 | 116 | 7 | GO:0031985 | |
| GeneOntologyCellularComponent | NMDA selective glutamate receptor complex | 1.37e-05 | 9 | 116 | 3 | GO:0017146 | |
| GeneOntologyCellularComponent | extrinsic component of cytoplasmic side of plasma membrane | 1.47e-05 | 56 | 116 | 5 | GO:0031234 | |
| GeneOntologyCellularComponent | postsynaptic membrane | GRIN2A GRIN2C GRIN2D DBN1 GPR179 IL1RAPL1 PTPRZ1 GNAO1 SLC16A7 CDH9 CNTN1 | 1.60e-05 | 405 | 116 | 11 | GO:0045211 |
| GeneOntologyCellularComponent | coated vesicle membrane | 2.70e-05 | 215 | 116 | 8 | GO:0030662 | |
| GeneOntologyCellularComponent | recycling endosome | 3.39e-05 | 222 | 116 | 8 | GO:0055037 | |
| GeneOntologyCellularComponent | Golgi stack | 4.78e-05 | 171 | 116 | 7 | GO:0005795 | |
| GeneOntologyCellularComponent | endoplasmic reticulum protein-containing complex | 7.03e-05 | 125 | 116 | 6 | GO:0140534 | |
| GeneOntologyCellularComponent | extrinsic component of plasma membrane | 1.17e-04 | 137 | 116 | 6 | GO:0019897 | |
| GeneOntologyCellularComponent | axon | SLC12A6 CNTNAP1 GRIN2A PLXND1 DBN1 KATNA1 ZNF804A AR IL1RAPL1 PTPRZ1 KIF3C CTTN ENO2 CDH9 CNTN1 | 1.23e-04 | 891 | 116 | 15 | GO:0030424 |
| GeneOntologyCellularComponent | postsynapse | DOCK1 STRN3 GRIN2A GRIN2C GRIN2D DBN1 ZNF804A GPR179 IL1RAPL1 PTPRZ1 GNAO1 CTTN SLC16A7 CDH9 EPB41L1 CNTN1 | 1.59e-04 | 1018 | 116 | 16 | GO:0098794 |
| GeneOntologyCellularComponent | glutamatergic synapse | DOCK1 CNTNAP1 GRIN2A PLXND1 GRIN2C GRIN2D DBN1 IL1RAPL1 PTPRZ1 GNAO1 CTTN SLC16A7 CDH9 CNTN1 | 1.75e-04 | 817 | 116 | 14 | GO:0098978 |
| GeneOntologyCellularComponent | phosphopyruvate hydratase complex | 1.82e-04 | 4 | 116 | 2 | GO:0000015 | |
| GeneOntologyCellularComponent | endocytic vesicle membrane | 1.83e-04 | 212 | 116 | 7 | GO:0030666 | |
| GeneOntologyCellularComponent | membrane raft | 1.90e-04 | 362 | 116 | 9 | GO:0045121 | |
| GeneOntologyCellularComponent | membrane microdomain | 1.98e-04 | 364 | 116 | 9 | GO:0098857 | |
| GeneOntologyCellularComponent | membrane protein complex | HLA-A HLA-B HLA-C HLA-E HLA-G HLA-H NAPG CACHD1 GRIN2A GRIN2C GRIN2D TF ZAP70 MTX3 GNAO1 GNAT2 CTTN MTX1 ATP2A2 CDH9 | 2.07e-04 | 1498 | 116 | 20 | GO:0098796 |
| GeneOntologyCellularComponent | postsynaptic density membrane | 2.45e-04 | 157 | 116 | 6 | GO:0098839 | |
| GeneOntologyCellularComponent | phagocytic vesicle | 2.45e-04 | 157 | 116 | 6 | GO:0045335 | |
| GeneOntologyCellularComponent | endoplasmic reticulum membrane | PIGN HLA-A HLA-B HLA-C MCFD2 HLA-E HLA-G HLA-H GRIN2A GRIN2C GRIN2D CDKAL1 SIK2 SEL1L2 SUCO ATP2A2 ATP2A3 DUOXA2 | 2.70e-04 | 1293 | 116 | 18 | GO:0005789 |
| GeneOntologyCellularComponent | DNA repair complex | 2.72e-04 | 23 | 116 | 3 | GO:1990391 | |
| GeneOntologyCellularComponent | endoplasmic reticulum subcompartment | PIGN HLA-A HLA-B HLA-C MCFD2 HLA-E HLA-G HLA-H GRIN2A GRIN2C GRIN2D CDKAL1 SIK2 SEL1L2 SUCO ATP2A2 ATP2A3 DUOXA2 | 2.86e-04 | 1299 | 116 | 18 | GO:0098827 |
| GeneOntologyCellularComponent | endocytic vesicle | 2.94e-04 | 384 | 116 | 9 | GO:0030139 | |
| GeneOntologyCellularComponent | nuclear outer membrane-endoplasmic reticulum membrane network | PIGN HLA-A HLA-B HLA-C MCFD2 HLA-E HLA-G HLA-H GRIN2A GRIN2C GRIN2D CDKAL1 SIK2 SEL1L2 SUCO ATP2A2 ATP2A3 DUOXA2 | 3.69e-04 | 1327 | 116 | 18 | GO:0042175 |
| GeneOntologyCellularComponent | growth cone | 4.40e-04 | 245 | 116 | 7 | GO:0030426 | |
| GeneOntologyCellularComponent | site of polarized growth | 5.33e-04 | 253 | 116 | 7 | GO:0030427 | |
| GeneOntologyCellularComponent | DNA-dependent protein kinase-DNA ligase 4 complex | 6.30e-04 | 7 | 116 | 2 | GO:0005958 | |
| GeneOntologyCellularComponent | transport vesicle | HLA-A HLA-B HLA-C MCFD2 HLA-E HLA-G HLA-H MYRIP GRIN2A KIF3C | 6.34e-04 | 519 | 116 | 10 | GO:0030133 |
| GeneOntologyCellularComponent | Golgi apparatus subcompartment | 8.21e-04 | 443 | 116 | 9 | GO:0098791 | |
| GeneOntologyCellularComponent | coated vesicle | 9.05e-04 | 360 | 116 | 8 | GO:0030135 | |
| GeneOntologyCellularComponent | postsynaptic specialization membrane | 9.06e-04 | 201 | 116 | 6 | GO:0099634 | |
| GeneOntologyCellularComponent | dendrite | STRN3 GRIN2A DBN1 ZNF804A TF AR GPR179 IL1RAPL1 PTPRZ1 KIF3C GNAO1 CTTN CDH9 | 9.54e-04 | 858 | 116 | 13 | GO:0030425 |
| GeneOntologyCellularComponent | dendritic tree | STRN3 GRIN2A DBN1 ZNF804A TF AR GPR179 IL1RAPL1 PTPRZ1 KIF3C GNAO1 CTTN CDH9 | 9.74e-04 | 860 | 116 | 13 | GO:0097447 |
| GeneOntologyCellularComponent | nonhomologous end joining complex | 1.07e-03 | 9 | 116 | 2 | GO:0070419 | |
| GeneOntologyCellularComponent | platelet dense tubular network membrane | 1.07e-03 | 9 | 116 | 2 | GO:0031095 | |
| GeneOntologyCellularComponent | cell cortex | 1.10e-03 | 371 | 116 | 8 | GO:0005938 | |
| GeneOntologyCellularComponent | side of membrane | HLA-A HLA-B HLA-C HLA-E HLA-G HLA-H IDE ZAP70 JAK1 GNAO1 GNAT2 ATP2A2 CNTN1 | 1.14e-03 | 875 | 116 | 13 | GO:0098552 |
| GeneOntologyCellularComponent | early endosome membrane | 1.19e-03 | 212 | 116 | 6 | GO:0031901 | |
| GeneOntologyCellularComponent | transport vesicle membrane | 1.26e-03 | 293 | 116 | 7 | GO:0030658 | |
| GeneOntologyCellularComponent | platelet dense tubular network | 1.63e-03 | 11 | 116 | 2 | GO:0031094 | |
| GeneOntologyCellularComponent | parallel fiber to Purkinje cell synapse | 1.75e-03 | 43 | 116 | 3 | GO:0098688 | |
| GeneOntologyCellularComponent | mitotic spindle pole | 1.75e-03 | 43 | 116 | 3 | GO:0097431 | |
| GeneOntologyCellularComponent | extrinsic component of membrane | 1.80e-03 | 230 | 116 | 6 | GO:0019898 | |
| GeneOntologyCellularComponent | ionotropic glutamate receptor complex | 1.99e-03 | 45 | 116 | 3 | GO:0008328 | |
| GeneOntologyCellularComponent | vacuolar membrane | 2.08e-03 | 507 | 116 | 9 | GO:0005774 | |
| GeneOntologyCellularComponent | MIB complex | 2.29e-03 | 13 | 116 | 2 | GO:0140275 | |
| GeneOntologyCellularComponent | SAM complex | 2.29e-03 | 13 | 116 | 2 | GO:0001401 | |
| GeneOntologyCellularComponent | neuron to neuron synapse | GRIN2A GRIN2C GRIN2D DBN1 IL1RAPL1 PTPRZ1 SLC16A7 CDH9 EPB41L1 | 2.56e-03 | 523 | 116 | 9 | GO:0098984 |
| GeneOntologyCellularComponent | neurotransmitter receptor complex | 2.70e-03 | 50 | 116 | 3 | GO:0098878 | |
| GeneOntologyCellularComponent | cell projection membrane | 2.80e-03 | 431 | 116 | 8 | GO:0031253 | |
| GeneOntologyCellularComponent | distal axon | 2.96e-03 | 435 | 116 | 8 | GO:0150034 | |
| GeneOntologyCellularComponent | anchoring junction | DSC3 CNTNAP1 DBN1 GRHL2 YWHAB ZAP70 JAK1 MAPRE1 DSG4 CTTN ATP2A2 CDH9 ARHGAP21 | 2.98e-03 | 976 | 116 | 13 | GO:0070161 |
| GeneOntologyCellularComponent | excitatory synapse | 2.99e-03 | 107 | 116 | 4 | GO:0060076 | |
| GeneOntologyCellularComponent | chromosome, telomeric region | 3.02e-03 | 176 | 116 | 5 | GO:0000781 | |
| GeneOntologyCellularComponent | somatodendritic compartment | STRN3 GRIN2A DBN1 KATNA1 ZNF804A TF AR GPR179 IL1RAPL1 PTPRZ1 KIF3C GNAO1 CTTN ENO2 CDH9 | 3.26e-03 | 1228 | 116 | 15 | GO:0036477 |
| GeneOntologyCellularComponent | postsynaptic density | 3.69e-03 | 451 | 116 | 8 | GO:0014069 | |
| GeneOntologyCellularComponent | cytoplasmic side of plasma membrane | 3.74e-03 | 185 | 116 | 5 | GO:0009898 | |
| GeneOntologyCellularComponent | cell tip | 3.93e-03 | 17 | 116 | 2 | GO:0051286 | |
| GeneOntologyCellularComponent | lysosomal membrane | 4.26e-03 | 462 | 116 | 8 | GO:0005765 | |
| GeneOntologyCellularComponent | lytic vacuole membrane | 4.26e-03 | 462 | 116 | 8 | GO:0098852 | |
| GeneOntologyCellularComponent | presynaptic membrane | 4.52e-03 | 277 | 116 | 6 | GO:0042734 | |
| GeneOntologyCellularComponent | postsynaptic actin cytoskeleton | 4.91e-03 | 19 | 116 | 2 | GO:0098871 | |
| GeneOntologyCellularComponent | asymmetric synapse | 5.15e-03 | 477 | 116 | 8 | GO:0032279 | |
| GeneOntologyCellularComponent | early endosome | 5.41e-03 | 481 | 116 | 8 | GO:0005769 | |
| GeneOntologyCellularComponent | cell pole | 5.43e-03 | 20 | 116 | 2 | GO:0060187 | |
| GeneOntologyCellularComponent | cortical cytoskeleton | 5.82e-03 | 129 | 116 | 4 | GO:0030863 | |
| GeneOntologyCellularComponent | hippocampal mossy fiber to CA3 synapse | 6.16e-03 | 67 | 116 | 3 | GO:0098686 | |
| GeneOntologyCellularComponent | mitochondrial outer membrane translocase complex | 6.56e-03 | 22 | 116 | 2 | GO:0005742 | |
| GeneOntologyCellularComponent | postsynaptic specialization | 7.02e-03 | 503 | 116 | 8 | GO:0099572 | |
| GeneOntologyCellularComponent | outer mitochondrial membrane protein complex | 7.16e-03 | 23 | 116 | 2 | GO:0098799 | |
| GeneOntologyCellularComponent | myelin sheath | 7.28e-03 | 217 | 116 | 5 | GO:0043209 | |
| GeneOntologyCellularComponent | photoreceptor cell cilium | 7.55e-03 | 139 | 116 | 4 | GO:0097733 | |
| GeneOntologyCellularComponent | postsynaptic cytoskeleton | 9.10e-03 | 26 | 116 | 2 | GO:0099571 | |
| GeneOntologyCellularComponent | cytoplasmic side of membrane | 9.23e-03 | 230 | 116 | 5 | GO:0098562 | |
| GeneOntologyCellularComponent | photoreceptor inner segment | 9.37e-03 | 78 | 116 | 3 | GO:0001917 | |
| GeneOntologyCellularComponent | 9+0 non-motile cilium | 1.05e-02 | 153 | 116 | 4 | GO:0097731 | |
| GeneOntologyCellularComponent | microtubule plus-end | 1.05e-02 | 28 | 116 | 2 | GO:0035371 | |
| GeneOntologyCellularComponent | desmosome | 1.05e-02 | 28 | 116 | 2 | GO:0030057 | |
| GeneOntologyCellularComponent | centrosome | 1.06e-02 | 770 | 116 | 10 | GO:0005813 | |
| MousePheno | spinal cord inflammation | 3.39e-12 | 8 | 101 | 6 | MP:0030987 | |
| MousePheno | decreased immature NK cell number | 3.39e-08 | 14 | 101 | 5 | MP:0013666 | |
| MousePheno | decreased gamma-delta T cell number | 4.13e-08 | 47 | 101 | 7 | MP:0008347 | |
| MousePheno | CNS inflammation | 1.12e-07 | 54 | 101 | 7 | MP:0006082 | |
| MousePheno | decreased mature NK cell number | 1.42e-07 | 18 | 101 | 5 | MP:0013672 | |
| MousePheno | abnormal immature NK cell number | 1.91e-07 | 19 | 101 | 5 | MP:0013665 | |
| MousePheno | abnormal immature NK cell morphology | 1.91e-07 | 19 | 101 | 5 | MP:0013699 | |
| MousePheno | cystolithiasis | 4.26e-07 | 22 | 101 | 5 | MP:0011625 | |
| MousePheno | abnormal gamma-delta T cell number | 6.23e-07 | 69 | 101 | 7 | MP:0008345 | |
| MousePheno | abnormal mature NK cell number | 6.79e-07 | 24 | 101 | 5 | MP:0013671 | |
| MousePheno | decreased susceptibility to autoimmune diabetes | 7.94e-07 | 45 | 101 | 6 | MP:0004804 | |
| MousePheno | abnormal mature NK cell morphology | 8.44e-07 | 25 | 101 | 5 | MP:0013700 | |
| MousePheno | increased CD4-positive, alpha-beta T cell number | COL10A1 HLA-A HLA-B HLA-C HLA-E HLA-G HLA-H ZAP70 LIG4 PRKDC DUOXA2 | 1.29e-06 | 241 | 101 | 11 | MP:0008074 |
| MousePheno | abnormal gamma-delta T cell morphology | 1.45e-06 | 78 | 101 | 7 | MP:0008343 | |
| MousePheno | increased NK cell number | 2.03e-06 | 82 | 101 | 7 | MP:0008044 | |
| MousePheno | increased alpha-beta T cell number | COL10A1 HLA-A HLA-B HLA-C HLA-E HLA-G HLA-H DBN1 ZAP70 LIG4 PRKDC DUOXA2 | 2.42e-06 | 311 | 101 | 12 | MP:0012764 |
| MousePheno | decreased NK cell number | 2.42e-06 | 120 | 101 | 8 | MP:0008045 | |
| MousePheno | demyelination | 2.59e-06 | 85 | 101 | 7 | MP:0000921 | |
| MousePheno | urolithiasis | 2.61e-06 | 31 | 101 | 5 | MP:0005360 | |
| MousePheno | abnormal myelination | 3.10e-06 | 166 | 101 | 9 | MP:0000920 | |
| MousePheno | decreased CD8-positive, alpha-beta T cell number | 3.86e-06 | 218 | 101 | 10 | MP:0008079 | |
| MousePheno | abnormal NK cell number | 4.15e-06 | 172 | 101 | 9 | MP:0008043 | |
| MousePheno | abnormal NK cell morphology | 6.88e-06 | 183 | 101 | 9 | MP:0005068 | |
| MousePheno | abnormal T cell activation | HLA-A HLA-B HLA-C HLA-E HLA-G HLA-H NUP98 ZAP70 LIG4 PRKDC EIF2AK2 | 1.48e-05 | 311 | 101 | 11 | MP:0001828 |
| MousePheno | decreased alpha-beta T cell number | HLA-A HLA-B HLA-C HLA-E HLA-G HLA-H NUP98 ZAP70 LIG4 PRKDC DUOXA2 | 1.67e-05 | 315 | 101 | 11 | MP:0012765 |
| MousePheno | abnormal CD4-positive, alpha-beta T cell number | COL10A1 HLA-A HLA-B HLA-C HLA-E HLA-G HLA-H NUP98 ZAP70 LIG4 PRKDC DUOXA2 | 2.45e-05 | 391 | 101 | 12 | MP:0008073 |
| MousePheno | abnormal alpha-beta T cell number | COL10A1 ZBTB16 HLA-A HLA-B HLA-C HLA-E HLA-G HLA-H NUP98 DBN1 ZAP70 LIG4 PRKDC DUOXA2 | 3.38e-05 | 542 | 101 | 14 | MP:0012763 |
| MousePheno | increased T cell number | COL10A1 HLA-A HLA-B HLA-C HLA-E HLA-G HLA-H DBN1 ZAP70 JAK1 LIG4 PRKDC DUOXA2 | 3.65e-05 | 475 | 101 | 13 | MP:0005015 |
| MousePheno | abnormal CD8-positive, alpha-beta T cell number | HLA-A HLA-B HLA-C HLA-E HLA-G HLA-H DBN1 ZAP70 LIG4 PRKDC DUOXA2 | 4.63e-05 | 352 | 101 | 11 | MP:0008077 |
| MousePheno | decreased T cell number | COL10A1 ZBTB16 HLA-A HLA-B HLA-C HLA-E HLA-G HLA-H NUP98 ZAP70 JAK1 LIG4 PRKDC DUOXA2 | 5.41e-05 | 566 | 101 | 14 | MP:0005018 |
| MousePheno | abnormal CD4-positive, alpha beta T cell morphology | COL10A1 HLA-A HLA-B HLA-C HLA-E HLA-G HLA-H NUP98 ZAP70 LIG4 PRKDC DUOXA2 | 7.20e-05 | 437 | 101 | 12 | MP:0002432 |
| MousePheno | abnormal CD8-positive, alpha beta T cell morphology | HLA-A HLA-B HLA-C HLA-E HLA-G HLA-H DBN1 ZAP70 LIG4 PRKDC DUOXA2 | 9.00e-05 | 379 | 101 | 11 | MP:0005010 |
| MousePheno | abnormal vascular endothelial cell migration | 1.56e-04 | 15 | 101 | 3 | MP:0003544 | |
| MousePheno | abnormal effector T cell morphology | COL10A1 ZBTB16 HLA-A HLA-B HLA-C HLA-E HLA-G HLA-H NUP98 DBN1 ZAP70 LIG4 PRKDC DUOXA2 | 1.66e-04 | 629 | 101 | 14 | MP:0002435 |
| MousePheno | increased lymphocyte cell number | COL10A1 HLA-A HLA-B HLA-C HLA-E HLA-G HLA-H DBN1 TF AR ZAP70 JAK1 LIG4 PRKDC CLSPN DUOXA2 | 1.80e-04 | 797 | 101 | 16 | MP:0005013 |
| MousePheno | abnormal alpha-beta T cell morphology | COL10A1 ZBTB16 HLA-A HLA-B HLA-C HLA-E HLA-G HLA-H NUP98 DBN1 ZAP70 LIG4 PRKDC DUOXA2 | 1.98e-04 | 640 | 101 | 14 | MP:0012762 |
| MousePheno | decreased fetal size | 2.51e-04 | 229 | 101 | 8 | MP:0004200 | |
| MousePheno | enhanced liver regeneration | 3.07e-04 | 4 | 101 | 2 | MP:0005516 | |
| MousePheno | abnormal fetal size | 3.16e-04 | 237 | 101 | 8 | MP:0004198 | |
| MousePheno | decreased susceptibility to autoimmune disorder | 3.25e-04 | 180 | 101 | 7 | MP:0005351 | |
| MousePheno | lethality at weaning, complete penetrance | 3.32e-04 | 46 | 101 | 4 | MP:0011083 | |
| MousePheno | decreased mean platelet volume | 4.24e-04 | 49 | 101 | 4 | MP:0008935 | |
| MousePheno | autoimmune response | 5.98e-04 | 398 | 101 | 10 | MP:0001844 | |
| MousePheno | abnormal self tolerance | 6.22e-04 | 400 | 101 | 10 | MP:0005005 | |
| MousePheno | abnormal immune tolerance | 6.72e-04 | 404 | 101 | 10 | MP:0005000 | |
| MousePheno | abnormal thymus size | DOCK1 COL10A1 ISM1 WRN PLXND1 ZAP70 JAK1 LIG4 BRCA2 PTPRZ1 PRKDC CA6 | 7.46e-04 | 564 | 101 | 12 | MP:0002364 |
| MousePheno | abnormal T cell number | COL10A1 ZBTB16 HLA-A HLA-B HLA-C HLA-E HLA-G HLA-H NUP98 DBN1 ZAP70 JAK1 LIG4 PRKDC DUOXA2 | 7.56e-04 | 818 | 101 | 15 | MP:0006387 |
| MousePheno | abnormal T cell receptor beta chain V(D)J recombination | 7.61e-04 | 6 | 101 | 2 | MP:0008758 | |
| MousePheno | thymus hypoplasia | 8.12e-04 | 152 | 101 | 6 | MP:0001823 | |
| Domain | MHC_I_a_C | 5.52e-11 | 6 | 118 | 5 | IPR010579 | |
| Domain | MHC_I_C | 5.52e-11 | 6 | 118 | 5 | PF06623 | |
| Domain | MHC_I | 2.81e-09 | 21 | 118 | 6 | PF00129 | |
| Domain | MHC_I_a_a1/a2 | 2.81e-09 | 21 | 118 | 6 | IPR001039 | |
| Domain | - | 3.57e-07 | 24 | 118 | 5 | 3.30.500.10 | |
| Domain | MHC_I-like_Ag-recog | 3.57e-07 | 24 | 118 | 5 | IPR011161 | |
| Domain | C1-set | 1.13e-06 | 54 | 118 | 6 | PF07654 | |
| Domain | IGc1 | 1.40e-06 | 56 | 118 | 6 | SM00407 | |
| Domain | Ig/MHC_CS | 1.73e-06 | 58 | 118 | 6 | IPR003006 | |
| Domain | Ig_C1-set | 1.73e-06 | 58 | 118 | 6 | IPR003597 | |
| Domain | IG_MHC | 2.12e-06 | 60 | 118 | 6 | PS00290 | |
| Domain | MHC_I/II-like_Ag-recog | 3.93e-06 | 38 | 118 | 5 | IPR011162 | |
| Domain | Enolase_N | 1.18e-04 | 3 | 118 | 2 | PF03952 | |
| Domain | Enolase | 1.18e-04 | 3 | 118 | 2 | IPR000941 | |
| Domain | Sam37/metaxin_N | 1.18e-04 | 3 | 118 | 2 | IPR019564 | |
| Domain | Enolase_C | 1.18e-04 | 3 | 118 | 2 | IPR020810 | |
| Domain | Enolase_N | 1.18e-04 | 3 | 118 | 2 | IPR020811 | |
| Domain | Enolase_CS | 1.18e-04 | 3 | 118 | 2 | IPR020809 | |
| Domain | NMDAR2_C | 1.18e-04 | 3 | 118 | 2 | PF10565 | |
| Domain | Enolase_C | 1.18e-04 | 3 | 118 | 2 | PF00113 | |
| Domain | Tom37 | 1.18e-04 | 3 | 118 | 2 | PF10568 | |
| Domain | Enolase_N | 1.18e-04 | 3 | 118 | 2 | SM01193 | |
| Domain | NMDAR2_C | 1.18e-04 | 3 | 118 | 2 | IPR018884 | |
| Domain | Enolase_C | 1.18e-04 | 3 | 118 | 2 | SM01192 | |
| Domain | P-type_ATPase_IIA | 1.18e-04 | 3 | 118 | 2 | IPR005782 | |
| Domain | ENOLASE | 1.18e-04 | 3 | 118 | 2 | PS00164 | |
| Domain | Lig_chan-Glu_bd | 1.87e-04 | 18 | 118 | 3 | PF10613 | |
| Domain | Glu/Gly-bd | 1.87e-04 | 18 | 118 | 3 | IPR019594 | |
| Domain | Lig_chan-Glu_bd | 1.87e-04 | 18 | 118 | 3 | SM00918 | |
| Domain | Iontro_rcpt | 1.87e-04 | 18 | 118 | 3 | IPR001320 | |
| Domain | Iono_rcpt_met | 1.87e-04 | 18 | 118 | 3 | IPR001508 | |
| Domain | Lig_chan | 1.87e-04 | 18 | 118 | 3 | PF00060 | |
| Domain | PBPe | 1.87e-04 | 18 | 118 | 3 | SM00079 | |
| Domain | - | 2.36e-04 | 4 | 118 | 2 | 3.30.390.10 | |
| Domain | Metaxin_GST | 2.36e-04 | 4 | 118 | 2 | IPR033468 | |
| Domain | - | 2.36e-04 | 4 | 118 | 2 | 3.20.20.120 | |
| Domain | GST_C_6 | 2.36e-04 | 4 | 118 | 2 | PF17171 | |
| Domain | Enolase_C-like | 2.36e-04 | 4 | 118 | 2 | IPR029065 | |
| Domain | Enolase_N-like | 2.36e-04 | 4 | 118 | 2 | IPR029017 | |
| Domain | Cadherin_C | 5.11e-04 | 25 | 118 | 3 | PF01049 | |
| Domain | Cadherin_cytoplasmic-dom | 5.11e-04 | 25 | 118 | 3 | IPR000233 | |
| Domain | TPR-like_helical_dom | 7.01e-04 | 233 | 118 | 7 | IPR011990 | |
| Domain | Catenin_binding_dom | 7.97e-04 | 29 | 118 | 3 | IPR027397 | |
| Domain | - | 7.97e-04 | 29 | 118 | 3 | 4.10.900.10 | |
| Domain | Desmosomal_cadherin | 8.14e-04 | 7 | 118 | 2 | IPR009122 | |
| Domain | Gprotein_alpha_I | 1.08e-03 | 8 | 118 | 2 | IPR001408 | |
| Domain | SLC12_C | 1.08e-03 | 8 | 118 | 2 | IPR018491 | |
| Domain | SEL1 | 1.08e-03 | 8 | 118 | 2 | SM00671 | |
| Domain | SLC12 | 1.08e-03 | 8 | 118 | 2 | PF03522 | |
| Domain | Sel1-like | 1.38e-03 | 9 | 118 | 2 | IPR006597 | |
| Domain | SH3_9 | 1.51e-03 | 78 | 118 | 4 | PF14604 | |
| Domain | ANF_lig-bd_rcpt | 1.63e-03 | 37 | 118 | 3 | IPR001828 | |
| Domain | ANF_receptor | 1.63e-03 | 37 | 118 | 3 | PF01094 | |
| Domain | Hydrolase_3 | 1.72e-03 | 10 | 118 | 2 | PF08282 | |
| Domain | EF-hand_4 | 1.72e-03 | 10 | 118 | 2 | PF12763 | |
| Domain | NA-bd_OB-fold | 1.89e-03 | 83 | 118 | 4 | IPR012340 | |
| Domain | Peripla_BP_I | 1.90e-03 | 39 | 118 | 3 | IPR028082 | |
| Domain | - | 2.03e-03 | 207 | 118 | 6 | 1.25.40.10 | |
| Domain | G-protein_beta_WD-40_rep | 2.07e-03 | 85 | 118 | 4 | IPR020472 | |
| Domain | EH | 2.10e-03 | 11 | 118 | 2 | PS50031 | |
| Domain | EH | 2.10e-03 | 11 | 118 | 2 | SM00027 | |
| Domain | EH_dom | 2.10e-03 | 11 | 118 | 2 | IPR000261 | |
| Domain | SH3_1 | 3.87e-03 | 164 | 118 | 5 | PF00018 | |
| Domain | GproteinA_insert | 4.48e-03 | 16 | 118 | 2 | IPR011025 | |
| Domain | - | 4.48e-03 | 16 | 118 | 2 | 1.10.400.10 | |
| Domain | ATPase_P-typ_TM_dom | 4.48e-03 | 16 | 118 | 2 | IPR023298 | |
| Domain | G-alpha | 4.48e-03 | 16 | 118 | 2 | PF00503 | |
| Domain | - | 4.48e-03 | 16 | 118 | 2 | 1.20.1110.10 | |
| Domain | G_alpha | 4.48e-03 | 16 | 118 | 2 | SM00275 | |
| Domain | ATPase_P-typ_cation-transptr_C | 5.06e-03 | 17 | 118 | 2 | IPR006068 | |
| Domain | Cation_ATPase_C | 5.06e-03 | 17 | 118 | 2 | PF00689 | |
| Domain | Carb_anhydrase | 5.06e-03 | 17 | 118 | 2 | PF00194 | |
| Domain | Carb_anhydrase | 5.06e-03 | 17 | 118 | 2 | SM01057 | |
| Domain | - | 5.06e-03 | 17 | 118 | 2 | 3.10.200.10 | |
| Domain | Gprotein_alpha_su | 5.06e-03 | 17 | 118 | 2 | IPR001019 | |
| Domain | ALPHA_CA_2 | 5.06e-03 | 17 | 118 | 2 | PS51144 | |
| Domain | Carbonic_anhydrase_a | 5.06e-03 | 17 | 118 | 2 | IPR001148 | |
| Domain | Ig-like_fold | HLA-A HLA-B HLA-C HLA-E HLA-G HLA-H PLXND1 IL1RAPL1 PTPRZ1 MID1 CNTN1 | 5.11e-03 | 706 | 118 | 11 | IPR013783 |
| Domain | Cation_ATPase_N | 5.67e-03 | 18 | 118 | 2 | PF00690 | |
| Domain | Cation_ATPase_N | 5.67e-03 | 18 | 118 | 2 | SM00831 | |
| Domain | ATPase_P-typ_cation-transptr_N | 6.31e-03 | 19 | 118 | 2 | IPR004014 | |
| Pathway | REACTOME_ENDOSOMAL_VACUOLAR_PATHWAY | 4.73e-12 | 9 | 90 | 6 | MM14527 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_KSHV_MIR1_2_TO_ANTIGEN_PROCESSING_AND_PRESENTATION_BY_MHC_CLASS_I_MOLECULES | 5.66e-11 | 6 | 90 | 5 | M47468 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HTLV_1_P12_TO_ANTIGEN_PROCESSING_AND_PRESENTATION_BY_MHC_CLASS_I_MOLECULES | 1.97e-10 | 7 | 90 | 5 | M47582 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HPV_E5_TO_ANTIGEN_PROCESSING_AND_PRESENTATION_BY_MHC_CLASS_I_MOLECULES | 1.97e-10 | 7 | 90 | 5 | M47530 | |
| Pathway | REACTOME_ER_PHAGOSOME_PATHWAY | 9.98e-10 | 18 | 90 | 6 | MM14525 | |
| Pathway | BIOCARTA_CTL_PATHWAY | 2.06e-09 | 20 | 90 | 6 | MM1374 | |
| Pathway | REACTOME_ENDOSOMAL_VACUOLAR_PATHWAY | 4.25e-09 | 11 | 90 | 5 | M525 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ANTIGEN_PROCESSING_AND_PRESENTATION_BY_MHC_CLASS_I_MOLECULES | 7.25e-09 | 12 | 90 | 5 | M47529 | |
| Pathway | REACTOME_ANTIGEN_PRESENTATION_FOLDING_ASSEMBLY_AND_PEPTIDE_LOADING_OF_CLASS_I_MHC | 9.19e-09 | 25 | 90 | 6 | MM15713 | |
| Pathway | BIOCARTA_NKCELLS_PATHWAY | 9.19e-09 | 25 | 90 | 6 | MM1465 | |
| Pathway | REACTOME_INTERFERON_ALPHA_BETA_SIGNALING | 3.27e-08 | 78 | 90 | 8 | M973 | |
| Pathway | REACTOME_INTERFERON_GAMMA_SIGNALING | 1.98e-07 | 98 | 90 | 8 | M965 | |
| Pathway | REACTOME_ANTIGEN_PRESENTATION_FOLDING_ASSEMBLY_AND_PEPTIDE_LOADING_OF_CLASS_I_MHC | 9.98e-07 | 29 | 90 | 5 | M1062 | |
| Pathway | REACTOME_DAP12_INTERACTIONS | 1.16e-06 | 54 | 90 | 6 | MM14871 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TRANSPORT_OF_CALCIUM | 2.49e-06 | 5 | 90 | 3 | M47667 | |
| Pathway | REACTOME_ASSEMBLY_AND_CELL_SURFACE_PRESENTATION_OF_NMDA_RECEPTORS | 2.49e-06 | 5 | 90 | 3 | MM15655 | |
| Pathway | KEGG_ALLOGRAFT_REJECTION | 3.52e-06 | 37 | 90 | 5 | M18615 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_PDYN_TO_TRANSPORT_OF_CALCIUM | 4.96e-06 | 6 | 90 | 3 | M47668 | |
| Pathway | KEGG_GRAFT_VERSUS_HOST_DISEASE | 5.93e-06 | 41 | 90 | 5 | M13519 | |
| Pathway | REACTOME_SARS_COV_2_HOST_INTERACTIONS | 5.99e-06 | 204 | 90 | 9 | M45011 | |
| Pathway | WP_ALZHEIMERS_DISEASE | 7.48e-06 | 74 | 90 | 6 | MM15962 | |
| Pathway | KEGG_TYPE_I_DIABETES_MELLITUS | 7.54e-06 | 43 | 90 | 5 | M12617 | |
| Pathway | REACTOME_ANTIGEN_PROCESSING_CROSS_PRESENTATION | 8.74e-06 | 76 | 90 | 6 | MM14526 | |
| Pathway | REACTOME_INTERFERON_SIGNALING | 9.21e-06 | 273 | 90 | 10 | M983 | |
| Pathway | REACTOME_SARS_COV_2_ACTIVATES_MODULATES_INNATE_AND_ADAPTIVE_IMMUNE_RESPONSES | 1.56e-05 | 126 | 90 | 7 | M45009 | |
| Pathway | KEGG_AUTOIMMUNE_THYROID_DISEASE | 1.95e-05 | 52 | 90 | 5 | M13103 | |
| Pathway | KEGG_CELL_ADHESION_MOLECULES_CAMS | 2.21e-05 | 133 | 90 | 7 | M16476 | |
| Pathway | WP_PROTEASOME_DEGRADATION | 2.80e-05 | 56 | 90 | 5 | MM15901 | |
| Pathway | WP_NONHOMOLOGOUS_END_JOINING | 2.92e-05 | 10 | 90 | 3 | M39469 | |
| Pathway | WP_PROTEASOME_DEGRADATION | 4.61e-05 | 62 | 90 | 5 | M39639 | |
| Pathway | WP_TAR_SYNDROME | 4.98e-05 | 63 | 90 | 5 | M48082 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CA2_ENTRY_LIGAND_GATED_CA2_CHANNEL | 5.31e-05 | 12 | 90 | 3 | M47953 | |
| Pathway | KEGG_VIRAL_MYOCARDITIS | 8.28e-05 | 70 | 90 | 5 | M12294 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_TRANSPORT_OF_CALCIUM | 1.08e-04 | 15 | 90 | 3 | M47691 | |
| Pathway | REACTOME_SARS_COV_2_INFECTION | 1.21e-04 | 299 | 90 | 9 | M41727 | |
| Pathway | WP_EBOLA_VIRUS_INFECTION_IN_HOST | 1.74e-04 | 129 | 90 | 6 | M39693 | |
| Pathway | WP_NRXN1_DELETION_SYNDROME | 1.92e-04 | 18 | 90 | 3 | M48098 | |
| Pathway | KEGG_MEDICUS_VARIANT_SCRAPIE_CONFORMATION_PRPSC_TO_TRANSPORT_OF_CALCIUM | 1.92e-04 | 18 | 90 | 3 | M47761 | |
| Pathway | REACTOME_IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL | 2.22e-04 | 135 | 90 | 6 | MM14781 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_TRANSPORT_OF_CALCIUM | 2.26e-04 | 19 | 90 | 3 | M47677 | |
| Pathway | REACTOME_PROTEIN_PROTEIN_INTERACTIONS_AT_SYNAPSES | 2.32e-04 | 87 | 90 | 5 | M27617 | |
| Pathway | KEGG_NATURAL_KILLER_CELL_MEDIATED_CYTOTOXICITY | 2.41e-04 | 137 | 90 | 6 | M5669 | |
| Pathway | KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION | 2.45e-04 | 88 | 90 | 5 | M16004 | |
| Pathway | WP_ALLOGRAFT_REJECTION | 2.58e-04 | 89 | 90 | 5 | M39398 | |
| Pathway | BIOCARTA_NOS1_PATHWAY | 2.65e-04 | 20 | 90 | 3 | MM1445 | |
| Pathway | REACTOME_SYNAPTIC_ADHESION_LIKE_MOLECULES | 2.65e-04 | 20 | 90 | 3 | MM15485 | |
| Pathway | REACTOME_SYNAPTIC_ADHESION_LIKE_MOLECULES | 3.08e-04 | 21 | 90 | 3 | M27736 | |
| Pathway | BIOCARTA_NOS1_PATHWAY | 3.08e-04 | 21 | 90 | 3 | M11650 | |
| Pathway | REACTOME_UNBLOCKING_OF_NMDA_RECEPTORS_GLUTAMATE_BINDING_AND_ACTIVATION | 3.08e-04 | 21 | 90 | 3 | M838 | |
| Pathway | REACTOME_NEGATIVE_REGULATION_OF_NMDA_RECEPTOR_MEDIATED_NEURONAL_TRANSMISSION | 3.08e-04 | 21 | 90 | 3 | M27944 | |
| Pathway | REACTOME_UNBLOCKING_OF_NMDA_RECEPTORS_GLUTAMATE_BINDING_AND_ACTIVATION | 3.55e-04 | 22 | 90 | 3 | MM15104 | |
| Pathway | REACTOME_LONG_TERM_POTENTIATION | 4.06e-04 | 23 | 90 | 3 | M27949 | |
| Pathway | REACTOME_NEUREXINS_AND_NEUROLIGINS | 4.43e-04 | 56 | 90 | 4 | M27616 | |
| Pathway | WP_MTHFR_DEFICIENCY | 4.62e-04 | 24 | 90 | 3 | M39755 | |
| Pathway | REACTOME_ANTIGEN_PROCESSING_CROSS_PRESENTATION | 5.79e-04 | 106 | 90 | 5 | M518 | |
| Pathway | REACTOME_SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3 | DOCK1 NUP98 PLXND1 DBN1 ARHGEF17 YWHAB AR ZAP70 MAPRE1 ITSN2 CTTN MTX1 ARHGAP21 | 6.24e-04 | 720 | 90 | 13 | M41838 |
| Pathway | KEGG_ALZHEIMERS_DISEASE | 6.71e-04 | 166 | 90 | 6 | M16024 | |
| Pathway | REACTOME_NEUROFASCIN_INTERACTIONS | 8.29e-04 | 7 | 90 | 2 | M27380 | |
| Pathway | REACTOME_PROTEIN_PROTEIN_INTERACTIONS_AT_SYNAPSES | 8.76e-04 | 67 | 90 | 4 | MM15327 | |
| Pathway | KEGG_ENDOCYTOSIS | 1.05e-03 | 181 | 90 | 6 | M1519 | |
| Pathway | KEGG_MEDICUS_REFERENCE_REGULATION_OF_SERCA | 1.10e-03 | 8 | 90 | 2 | M47955 | |
| Pathway | WP_DISRUPTION_OF_POSTSYNAPTIC_SIGNALING_BY_CNV | 1.20e-03 | 33 | 90 | 3 | M39875 | |
| Pathway | WP_ALZHEIMERS_DISEASE | 1.39e-03 | 261 | 90 | 7 | M42565 | |
| Pathway | REACTOME_ACTIVATION_OF_NMDA_RECEPTORS_AND_POSTSYNAPTIC_EVENTS | 1.42e-03 | 35 | 90 | 3 | MM15109 | |
| Pathway | WP_VITAMIN_DSENSITIVE_CALCIUM_SIGNALING_IN_DEPRESSION | 1.54e-03 | 36 | 90 | 3 | M39831 | |
| Pathway | WP_TYPE_II_INTERFERON_SIGNALING | 1.67e-03 | 37 | 90 | 3 | M39363 | |
| Pathway | WP_DNA_IRDAMAGE_AND_CELLULAR_RESPONSE_VIA_ATR | 1.78e-03 | 81 | 90 | 4 | M39490 | |
| Pathway | PID_ATR_PATHWAY | 1.95e-03 | 39 | 90 | 3 | M46 | |
| Pathway | WP_MALE_INFERTILITY | 2.34e-03 | 145 | 90 | 5 | M39856 | |
| Pathway | REACTOME_DNA_DOUBLE_STRAND_BREAK_REPAIR | 2.41e-03 | 146 | 90 | 5 | MM15292 | |
| Pathway | REACTOME_REDUCTION_OF_CYTOSOLIC_CA_LEVELS | 2.55e-03 | 12 | 90 | 2 | M27326 | |
| Pathway | KEGG_MEDICUS_REFERENCE_V_D_J_RECOMBINATION | 2.55e-03 | 12 | 90 | 2 | M47856 | |
| Pathway | REACTOME_SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3 | DOCK1 NUP98 PLXND1 ARHGEF17 YWHAB AR ZAP70 MAPRE1 ITSN2 MTX1 ARHGAP21 | 2.75e-03 | 649 | 90 | 11 | MM15690 |
| Pathway | REACTOME_ASSEMBLY_AND_CELL_SURFACE_PRESENTATION_OF_NMDA_RECEPTORS | 2.76e-03 | 44 | 90 | 3 | M27934 | |
| Pathway | KEGG_NON_HOMOLOGOUS_END_JOINING | 3.00e-03 | 13 | 90 | 2 | M7857 | |
| Pathway | KEGG_MEDICUS_REFERENCE_NON_HOMOLOGOUS_END_JOINING | 3.00e-03 | 13 | 90 | 2 | M47837 | |
| Pathway | REACTOME_SARS_COV_INFECTIONS | 3.09e-03 | 471 | 90 | 9 | M39009 | |
| Pathway | REACTOME_DAP12_INTERACTIONS | 3.13e-03 | 46 | 90 | 3 | M27151 | |
| Pathway | WP_NOCGMPPKG_MEDIATED_NEUROPROTECTION | 3.33e-03 | 47 | 90 | 3 | M39531 | |
| Pubmed | Association of brain immune genes with social behavior of inbred mouse strains. | 5.46e-16 | 10 | 119 | 7 | 25895500 | |
| Pubmed | 5.46e-16 | 10 | 119 | 7 | 37712758 | ||
| Pubmed | 5.46e-16 | 10 | 119 | 7 | 38426910 | ||
| Pubmed | 5.46e-16 | 10 | 119 | 7 | 37219526 | ||
| Pubmed | 5.46e-16 | 10 | 119 | 7 | 37966111 | ||
| Pubmed | 5.46e-16 | 10 | 119 | 7 | 37877672 | ||
| Pubmed | 5.46e-16 | 10 | 119 | 7 | 23869841 | ||
| Pubmed | 5.46e-16 | 10 | 119 | 7 | 37715782 | ||
| Pubmed | 3.58e-15 | 12 | 119 | 7 | 20674402 | ||
| Pubmed | 9.86e-15 | 7 | 119 | 6 | 2808323 | ||
| Pubmed | Direct link between mhc polymorphism, T cell avidity, and diversity in immune defense. | 9.86e-15 | 7 | 119 | 6 | 12459592 | |
| Pubmed | A saturation hypothesis to explain both enhanced and impaired learning with enhanced plasticity. | 9.86e-15 | 7 | 119 | 6 | 28234229 | |
| Pubmed | 9.86e-15 | 7 | 119 | 6 | 2642506 | ||
| Pubmed | 9.86e-15 | 7 | 119 | 6 | 9037062 | ||
| Pubmed | 9.86e-15 | 7 | 119 | 6 | 20957233 | ||
| Pubmed | 9.86e-15 | 7 | 119 | 6 | 11580250 | ||
| Pubmed | Convergent recombination shapes the clonotypic landscape of the naive T-cell repertoire. | 9.86e-15 | 7 | 119 | 6 | 20974936 | |
| Pubmed | 9.86e-15 | 7 | 119 | 6 | 10704462 | ||
| Pubmed | A novel H-2K splice form: predictions for other alternative H-2 splicing events. | 9.86e-15 | 7 | 119 | 6 | 2908875 | |
| Pubmed | 9.86e-15 | 7 | 119 | 6 | 3458188 | ||
| Pubmed | 9.86e-15 | 7 | 119 | 6 | 19462379 | ||
| Pubmed | 9.86e-15 | 7 | 119 | 6 | 6300887 | ||
| Pubmed | H-2-linked regulation of xenotropic murine leukemia virus expression. | 9.86e-15 | 7 | 119 | 6 | 6300850 | |
| Pubmed | 9.86e-15 | 7 | 119 | 6 | 8500526 | ||
| Pubmed | cDNA clone coding for part of a mouse H-2d major histocompatibility antigen. | 9.86e-15 | 7 | 119 | 6 | 6265910 | |
| Pubmed | DNA polymorphisms defined by the Tu108 probe map to the Tla region of mouse chromosome 17. | 9.86e-15 | 7 | 119 | 6 | 2906539 | |
| Pubmed | 9.86e-15 | 7 | 119 | 6 | 3013627 | ||
| Pubmed | 9.86e-15 | 7 | 119 | 6 | 3894562 | ||
| Pubmed | 9.86e-15 | 7 | 119 | 6 | 1348042 | ||
| Pubmed | H2-K(b) and H2-D(b) regulate cerebellar long-term depression and limit motor learning. | 9.86e-15 | 7 | 119 | 6 | 19346486 | |
| Pubmed | Liver sinusoidal endothelial cells veto CD8 T cell activation by antigen-presenting dendritic cells. | 9.86e-15 | 7 | 119 | 6 | 18383043 | |
| Pubmed | 9.86e-15 | 7 | 119 | 6 | 8833240 | ||
| Pubmed | 9.86e-15 | 7 | 119 | 6 | 21178009 | ||
| Pubmed | Extensive deletions in the Q region of the mouse major histocompatibility complex. | 9.86e-15 | 7 | 119 | 6 | 3025084 | |
| Pubmed | 9.86e-15 | 7 | 119 | 6 | 2989712 | ||
| Pubmed | Unique biochemical properties of a mutant MHC class I molecule, H-2Ksm1. | 9.86e-15 | 7 | 119 | 6 | 1280760 | |
| Pubmed | Three cDNA clones encoding mouse transplantation antigens: homology to immunoglobulin genes. | 9.86e-15 | 7 | 119 | 6 | 6786753 | |
| Pubmed | 9.86e-15 | 7 | 119 | 6 | 6583704 | ||
| Pubmed | 9.86e-15 | 7 | 119 | 6 | 6571712 | ||
| Pubmed | 9.86e-15 | 7 | 119 | 6 | 12006653 | ||
| Pubmed | 9.86e-15 | 7 | 119 | 6 | 7520098 | ||
| Pubmed | 9.86e-15 | 7 | 119 | 6 | 10452993 | ||
| Pubmed | 9.86e-15 | 7 | 119 | 6 | 26714929 | ||
| Pubmed | 9.86e-15 | 7 | 119 | 6 | 6280871 | ||
| Pubmed | 9.86e-15 | 7 | 119 | 6 | 10799615 | ||
| Pubmed | 9.86e-15 | 7 | 119 | 6 | 10993729 | ||
| Pubmed | MHC class I Dk locus and Ly49G2+ NK cells confer H-2k resistance to murine cytomegalovirus. | 9.86e-15 | 7 | 119 | 6 | 19454713 | |
| Pubmed | 9.86e-15 | 7 | 119 | 6 | 10229092 | ||
| Pubmed | 9.86e-15 | 7 | 119 | 6 | 2879284 | ||
| Pubmed | 9.86e-15 | 7 | 119 | 6 | 7306483 | ||
| Pubmed | 9.86e-15 | 7 | 119 | 6 | 2351932 | ||
| Pubmed | Nucleotide sequence analysis of H-2Df and the spontaneous in vivo H-2Dfm2 mutation. | 9.86e-15 | 7 | 119 | 6 | 1731192 | |
| Pubmed | 9.86e-15 | 7 | 119 | 6 | 1627536 | ||
| Pubmed | 9.86e-15 | 7 | 119 | 6 | 32341060 | ||
| Pubmed | H-2 class I and Gt (H-2) antigens are identical: evidence from H-2 mutant mice. | 9.86e-15 | 7 | 119 | 6 | 2422118 | |
| Pubmed | 9.86e-15 | 7 | 119 | 6 | 34181639 | ||
| Pubmed | 9.86e-15 | 7 | 119 | 6 | 15809355 | ||
| Pubmed | Thymus-leukemia (TL) antigens of the mouse. Analysis of TL mRNA and TL cDNA TL+ and TL- strains. | 9.86e-15 | 7 | 119 | 6 | 3840195 | |
| Pubmed | Mouse histocompatibility genes: structure and organisation of a Kd gene. | 9.86e-15 | 7 | 119 | 6 | 11894934 | |
| Pubmed | 9.86e-15 | 7 | 119 | 6 | 19700752 | ||
| Pubmed | 9.86e-15 | 7 | 119 | 6 | 11894963 | ||
| Pubmed | 9.86e-15 | 7 | 119 | 6 | 22287714 | ||
| Pubmed | 9.86e-15 | 7 | 119 | 6 | 2997361 | ||
| Pubmed | 9.86e-15 | 7 | 119 | 6 | 9869916 | ||
| Pubmed | 9.86e-15 | 7 | 119 | 6 | 312902 | ||
| Pubmed | 9.86e-15 | 7 | 119 | 6 | 3335396 | ||
| Pubmed | 9.86e-15 | 7 | 119 | 6 | 6689056 | ||
| Pubmed | 9.86e-15 | 7 | 119 | 6 | 16461341 | ||
| Pubmed | 9.86e-15 | 7 | 119 | 6 | 6895187 | ||
| Pubmed | Genetic control of corticosteroid side-chain isomerase activity in the mouse. | 9.86e-15 | 7 | 119 | 6 | 6822218 | |
| Pubmed | 9.86e-15 | 7 | 119 | 6 | 15210799 | ||
| Pubmed | NK gene complex and chromosome 19 loci enhance MHC resistance to murine cytomegalovirus infection. | 9.86e-15 | 7 | 119 | 6 | 19820922 | |
| Pubmed | 9.86e-15 | 7 | 119 | 6 | 8181071 | ||
| Pubmed | 9.86e-15 | 7 | 119 | 6 | 23142461 | ||
| Pubmed | Structure of C-terminal half of two H-2 antigens from cloned mRNA. | 9.86e-15 | 7 | 119 | 6 | 6895103 | |
| Pubmed | Nucleotide sequences of H2g7 K and D loci of nonobese diabetic mice. | 9.86e-15 | 7 | 119 | 6 | 7759137 | |
| Pubmed | 9.86e-15 | 7 | 119 | 6 | 6799575 | ||
| Pubmed | Qa antigen expression on functional lymphoid, myeloid, and stem cells in adult mice. | 9.86e-15 | 7 | 119 | 6 | 6966299 | |
| Pubmed | 9.86e-15 | 7 | 119 | 6 | 12140378 | ||
| Pubmed | 9.86e-15 | 7 | 119 | 6 | 2410925 | ||
| Pubmed | 9.86e-15 | 7 | 119 | 6 | 12421934 | ||
| Pubmed | 9.86e-15 | 7 | 119 | 6 | 3840763 | ||
| Pubmed | 9.86e-15 | 7 | 119 | 6 | 12421940 | ||
| Pubmed | 9.86e-15 | 7 | 119 | 6 | 9770513 | ||
| Pubmed | 9.86e-15 | 7 | 119 | 6 | 19195028 | ||
| Pubmed | 9.86e-15 | 7 | 119 | 6 | 16473882 | ||
| Pubmed | 9.86e-15 | 7 | 119 | 6 | 10479061 | ||
| Pubmed | Structural relationships among the H-2 D-regions of murine MHC haplotypes. | 9.86e-15 | 7 | 119 | 6 | 2909618 | |
| Pubmed | 9.86e-15 | 7 | 119 | 6 | 8168857 | ||
| Pubmed | 9.86e-15 | 7 | 119 | 6 | 20534453 | ||
| Pubmed | 9.86e-15 | 7 | 119 | 6 | 19342630 | ||
| Pubmed | Inactivation of the H-2Klk gene could involve the substitutions of methylated CpGs. | 9.86e-15 | 7 | 119 | 6 | 2212699 | |
| Pubmed | 9.86e-15 | 7 | 119 | 6 | 12817010 | ||
| Pubmed | 9.86e-15 | 7 | 119 | 6 | 7530689 | ||
| Pubmed | 9.86e-15 | 7 | 119 | 6 | 8781130 | ||
| Pubmed | VavP-Bcl2 transgenic mice develop follicular lymphoma preceded by germinal center hyperplasia. | 9.86e-15 | 7 | 119 | 6 | 14630790 | |
| Pubmed | 9.86e-15 | 7 | 119 | 6 | 1396970 | ||
| Pubmed | 9.86e-15 | 7 | 119 | 6 | 16054612 | ||
| Pubmed | 9.86e-15 | 7 | 119 | 6 | 8022824 | ||
| Pubmed | 9.86e-15 | 7 | 119 | 6 | 21690324 | ||
| Interaction | HLA-H interactions | 3.54e-08 | 17 | 117 | 5 | int:HLA-H | |
| Interaction | LILRB1 interactions | 2.21e-07 | 10 | 117 | 4 | int:LILRB1 | |
| Interaction | LILRB2 interactions | 2.21e-07 | 10 | 117 | 4 | int:LILRB2 | |
| Interaction | CD8A interactions | 3.61e-07 | 26 | 117 | 5 | int:CD8A | |
| Interaction | TAP2 interactions | 1.25e-06 | 94 | 117 | 7 | int:TAP2 | |
| Interaction | NR3C1 interactions | STRN3 ZBTB16 KDM5A HLA-H NUP98 LANCL1 MCM5 IDE NEB TF AR ANKRD36B IL1RAPL1 ITSN2 EHMT1 DSG4 PRKDC WDR17 EPB41L1 | 3.26e-06 | 974 | 117 | 19 | int:NR3C1 |
| Interaction | HLA-E interactions | 6.62e-06 | 79 | 117 | 6 | int:HLA-E | |
| Interaction | DLGAP1 interactions | 1.03e-05 | 180 | 117 | 8 | int:DLGAP1 | |
| Interaction | UFSP2 interactions | 3.21e-05 | 104 | 117 | 6 | int:UFSP2 | |
| Interaction | HTT interactions | SLC12A6 HLA-B CNTNAP1 NAPG GRIN2A DBN1 YWHAB BRCA2 MID1 GNAO1 GNAT2 MTX1 ATP2A2 ATP2A3 EIF2AK2 ENO3 CNTN1 | 3.37e-05 | 949 | 117 | 17 | int:HTT |
| Interaction | RAD9A interactions | 4.08e-05 | 66 | 117 | 5 | int:RAD9A | |
| Interaction | HLA-G interactions | 6.53e-05 | 118 | 117 | 6 | int:HLA-G | |
| Interaction | HLA-B interactions | 7.81e-05 | 239 | 117 | 8 | int:HLA-B | |
| Interaction | CPM interactions | 1.02e-04 | 42 | 117 | 4 | int:CPM | |
| Interaction | SYNJ2 interactions | 1.12e-04 | 43 | 117 | 4 | int:SYNJ2 | |
| Interaction | TINF2 interactions | 1.22e-04 | 132 | 117 | 6 | int:TINF2 | |
| Interaction | NHEJ1 interactions | 1.22e-04 | 17 | 117 | 3 | int:NHEJ1 | |
| Interaction | ABL1 interactions | 1.36e-04 | 259 | 117 | 8 | int:ABL1 | |
| Interaction | PUS7 interactions | 1.38e-04 | 135 | 117 | 6 | int:PUS7 | |
| Interaction | ARFGEF2 interactions | 1.43e-04 | 136 | 117 | 6 | int:ARFGEF2 | |
| Interaction | HLA-F interactions | 1.45e-04 | 86 | 117 | 5 | int:HLA-F | |
| Interaction | NEK4 interactions | HLA-B HLA-C ABCA13 HLA-E NUP98 MCM5 NEB YWHAB MAPRE1 DSG4 PRKDC ATP2A3 | 1.46e-04 | 582 | 117 | 12 | int:NEK4 |
| Interaction | RHOF interactions | DSC3 HLA-A HLA-B HLA-C MCM5 MELK EHD2 PRKDC ATP2A2 SLC16A7 EIF2AK2 ARHGAP21 EPB41L1 | 1.46e-04 | 673 | 117 | 13 | int:RHOF |
| Interaction | TIMELESS interactions | 1.49e-04 | 137 | 117 | 6 | int:TIMELESS | |
| Interaction | STK32C interactions | 1.53e-04 | 87 | 117 | 5 | int:STK32C | |
| Interaction | TERF1 interactions | 1.94e-04 | 347 | 117 | 9 | int:TERF1 | |
| Interaction | FOXO1 interactions | 1.94e-04 | 347 | 117 | 9 | int:FOXO1 | |
| Interaction | LRRC31 interactions | 1.96e-04 | 205 | 117 | 7 | int:LRRC31 | |
| Interaction | B2M interactions | 1.99e-04 | 92 | 117 | 5 | int:B2M | |
| Interaction | FER interactions | 2.02e-04 | 50 | 117 | 4 | int:FER | |
| Interaction | CDC42 interactions | DSC3 HLA-A HLA-B HLA-C WRN HLA-G BCCIP DBN1 MELK CDKAL1 EHD2 JAK1 MAPRE1 SIK2 PRKDC SLC16A7 EIF2AK2 ARHGAP21 EPB41L1 | 2.15e-04 | 1323 | 117 | 19 | int:CDC42 |
| Interaction | PRF1 interactions | 2.18e-04 | 51 | 117 | 4 | int:PRF1 | |
| Interaction | CLEC4E interactions | 2.20e-04 | 353 | 117 | 9 | int:CLEC4E | |
| Interaction | DAPK1 interactions | 2.21e-04 | 209 | 117 | 7 | int:DAPK1 | |
| Interaction | PLXNA3 interactions | 2.43e-04 | 96 | 117 | 5 | int:PLXNA3 | |
| Cytoband | 6p21.3 | 5.10e-05 | 250 | 119 | 6 | 6p21.3 | |
| GeneFamily | Histocompatibility complex|C1-set domain containing | 4.13e-08 | 44 | 81 | 6 | 588 | |
| GeneFamily | C1-set domain containing | 1.19e-06 | 42 | 81 | 5 | 591 | |
| GeneFamily | Glutamate ionotropic receptor NMDA type subunits | 2.99e-06 | 7 | 81 | 3 | 1201 | |
| GeneFamily | Desmosomal cadherins | 4.10e-04 | 7 | 81 | 2 | 1188 | |
| GeneFamily | ATPases Ca2+ transporting | 6.99e-04 | 9 | 81 | 2 | 1209 | |
| Coexpression | TABULA_MURIS_SENIS_LUNG_ENDOTHELIAL_CELL_OF_LYMPHATIC_VESSEL_AGEING | 5.65e-11 | 16 | 118 | 6 | MM3766 | |
| Coexpression | WUNDER_INFLAMMATORY_RESPONSE_AND_CHOLESTEROL_DN | 1.89e-10 | 19 | 118 | 6 | MM797 | |
| Coexpression | MIKKELSEN_NPC_ICP_WITH_H3K27ME3 | 1.89e-10 | 19 | 118 | 6 | MM862 | |
| Coexpression | TABULA_MURIS_SENIS_BLADDER_LEUKOCYTE_AGEING | 2.70e-10 | 20 | 118 | 6 | MM3682 | |
| Coexpression | RUAN_RESPONSE_TO_TNF_UP | 3.76e-10 | 21 | 118 | 6 | MM651 | |
| Coexpression | HOWLIN_CITED1_TARGETS_1_UP | 6.20e-10 | 41 | 118 | 7 | MM710 | |
| Coexpression | HU_GENOTOXIC_DAMAGE_4HR | 8.82e-10 | 43 | 118 | 7 | MM1204 | |
| Coexpression | TABULA_MURIS_SENIS_LUNG_PULMONARY_INTERSTITIAL_FIBROBLAST_AGEING | 9.22e-10 | 24 | 118 | 6 | MM3773 | |
| Coexpression | RUAN_RESPONSE_TO_TNF_TROGLITAZONE_UP | 1.21e-09 | 25 | 118 | 6 | MM672 | |
| Coexpression | TABULA_MURIS_SENIS_KIDNEY_KIDNEY_MESANGIAL_CELL_AGEING | 4.92e-09 | 31 | 118 | 6 | MM3729 | |
| Coexpression | TABULA_MURIS_SENIS_BRAIN_NON_MYELOID_INTERNEURON_AGEING | 8.80e-09 | 59 | 118 | 7 | MM3688 | |
| Coexpression | PAL_PRMT5_TARGETS_DN | 1.07e-08 | 35 | 118 | 6 | MM674 | |
| Coexpression | TABULA_MURIS_SENIS_LUNG_CD8_POSITIVE_ALPHA_BETA_T_CELL_AGEING | 2.12e-08 | 39 | 118 | 6 | MM3758 | |
| Coexpression | TABULA_MURIS_SENIS_KIDNEY_KIDNEY_CORTEX_ARTERY_CELL_AGEING | 2.12e-08 | 39 | 118 | 6 | MM3725 | |
| Coexpression | TABULA_MURIS_SENIS_LUNG_TYPE_II_PNEUMOCYTE_AGEING | 4.50e-08 | 44 | 118 | 6 | MM3775 | |
| Coexpression | TABULA_MURIS_SENIS_HEART_AND_AORTA_ENDOCARDIAL_CELL_AGEING | 5.92e-08 | 46 | 118 | 6 | MM3712 | |
| Coexpression | BAUS_TFF2_TARGETS_UP | 8.74e-08 | 49 | 118 | 6 | MM1287 | |
| Coexpression | TABULA_MURIS_SENIS_MARROW_MEGAKARYOCYTE_ERYTHROID_PROGENITOR_CELL_AGEING | 9.90e-08 | 50 | 118 | 6 | MM3805 | |
| Coexpression | WUNDER_INFLAMMATORY_RESPONSE_AND_CHOLESTEROL_UP | 1.07e-07 | 84 | 118 | 7 | MM1049 | |
| Coexpression | MA_RAT_AGING_UP | 1.14e-07 | 127 | 118 | 8 | MM16096 | |
| Coexpression | HOLLERN_MICROACINAR_BREAST_TUMOR_UP | 1.26e-07 | 52 | 118 | 6 | MM968 | |
| Coexpression | TABULA_MURIS_SENIS_MARROW_NAIVE_T_CELL_AGEING | 1.26e-07 | 52 | 118 | 6 | MM3808 | |
| Coexpression | TABULA_MURIS_SENIS_TONGUE_KERATINOCYTE_AGEING | 1.98e-07 | 56 | 118 | 6 | MM3852 | |
| Coexpression | JACKSON_DNMT1_TARGETS_UP | 2.15e-07 | 93 | 118 | 7 | MM1185 | |
| Coexpression | TABULA_MURIS_SENIS_HEART_AND_AORTA_SMOOTH_MUSCLE_CELL_AGEING | 2.20e-07 | 57 | 118 | 6 | MM3716 | |
| Coexpression | TABULA_MURIS_SENIS_HEART_ENDOCARDIAL_CELL_AGEING | 2.72e-07 | 59 | 118 | 6 | MM3704 | |
| Coexpression | MIKKELSEN_ES_ICP_WITH_H3K4ME3_AND_H3K27ME3 | 3.33e-07 | 146 | 118 | 8 | MM856 | |
| Coexpression | MARTINEZ_RB1_AND_TP53_TARGETS_UP | HLA-A HLA-B HLA-C HLA-E HLA-G HLA-H LANCL1 IDE TF JAK1 PTPRZ1 CTTN MTX1 SUCO ATP2A2 | 5.03e-07 | 689 | 118 | 15 | MM1041 |
| Coexpression | NATSUME_RESPONSE_TO_INTERFERON_BETA_UP | 7.59e-07 | 70 | 118 | 6 | M6897 | |
| Coexpression | GAURNIER_PSMD4_TARGETS | 9.75e-07 | 73 | 118 | 6 | M11428 | |
| Coexpression | TABULA_MURIS_SENIS_MARROW_GRANULOCYTE_AGEING | 1.06e-06 | 74 | 118 | 6 | MM3796 | |
| Coexpression | TABULA_MURIS_SENIS_LUNG_NK_CELL_AGEING | 1.14e-06 | 75 | 118 | 6 | MM3759 | |
| Coexpression | TABULA_MURIS_SENIS_KIDNEY_BRUSH_CELL_AGEING | 1.14e-06 | 75 | 118 | 6 | MM3718 | |
| Coexpression | TABULA_MURIS_SENIS_HEART_VENTRICULAR_MYOCYTE_AGEING | 1.22e-06 | 120 | 118 | 7 | MM3710 | |
| Coexpression | TABULA_MURIS_SENIS_KIDNEY_KIDNEY_LOOP_OF_HENLE_THICK_ASCENDING_LIMB_EPITHELIAL_CELL_AGEING | 1.37e-06 | 238 | 118 | 9 | MM3728 | |
| Coexpression | HOFFMANN_SMALL_PRE_BII_TO_IMMATURE_B_LYMPHOCYTE_DN | 1.60e-06 | 44 | 118 | 5 | MM805 | |
| Coexpression | TABULA_MURIS_SENIS_HEART_VALVE_CELL_AGEING | 1.70e-06 | 126 | 118 | 7 | MM3709 | |
| Coexpression | TABULA_MURIS_SENIS_MESENTERIC_ADIPOSE_TISSUE_B_CELL_AGEING | 1.94e-06 | 82 | 118 | 6 | MM3777 | |
| Coexpression | TABULA_MURIS_SENIS_TRACHEA_MACROPHAGE_AGEING | 1.94e-06 | 82 | 118 | 6 | MM3858 | |
| Coexpression | MIKKELSEN_MCV6_ICP_WITH_H3K27ME3 | 2.57e-06 | 86 | 118 | 6 | MM834 | |
| Coexpression | LEE_CALORIE_RESTRICTION_NEOCORTEX_UP | 2.75e-06 | 87 | 118 | 6 | MM652 | |
| Coexpression | CASTELLANO_NRAS_TARGETS_UP | 2.94e-06 | 88 | 118 | 6 | MM1087 | |
| Coexpression | MARTINEZ_TP53_TARGETS_UP | HLA-A HLA-B HLA-C HLA-E HLA-G HLA-H LANCL1 IDE TF JAK1 PTPRZ1 CTTN MTX1 SUCO | 3.01e-06 | 694 | 118 | 14 | MM1039 |
| Coexpression | TABULA_MURIS_SENIS_LUNG_B_CELL_AGEING | 3.35e-06 | 90 | 118 | 6 | MM3756 | |
| Coexpression | COATES_MACROPHAGE_M1_VS_M2_DN | 3.35e-06 | 90 | 118 | 6 | MM750 | |
| Coexpression | TABULA_MURIS_SENIS_HEART_ENDOTHELIAL_CELL_OF_CORONARY_ARTERY_AGEING | 3.43e-06 | 140 | 118 | 7 | MM3705 | |
| Coexpression | TABULA_MURIS_SENIS_KIDNEY_FENESTRATED_CELL_AGEING | 3.57e-06 | 91 | 118 | 6 | MM3720 | |
| Coexpression | TABULA_MURIS_SENIS_LIMB_MUSCLE_SMOOTH_MUSCLE_CELL_AGEING | 3.81e-06 | 92 | 118 | 6 | MM3748 | |
| Coexpression | TABULA_MURIS_SENIS_AORTA_PROFESSIONAL_ANTIGEN_PRESENTING_CELL_AGEING | 3.95e-06 | 143 | 118 | 7 | MM3673 | |
| Coexpression | TABULA_MURIS_SENIS_LIVER_HEPATOCYTE_AGEING | 4.74e-06 | 147 | 118 | 7 | MM3753 | |
| Coexpression | TABULA_MURIS_SENIS_SPLEEN_NK_CELL_AGEING | 4.88e-06 | 96 | 118 | 6 | MM3834 | |
| Coexpression | ZENG_GU_POST_ICB_METAGENE_31 | 4.93e-06 | 209 | 118 | 8 | MM17088 | |
| Coexpression | TABULA_MURIS_SENIS_MAMMARY_GLAND_MACROPHAGE_AGEING | 5.18e-06 | 97 | 118 | 6 | MM3789 | |
| Coexpression | ZENG_GU_ICB_CONTROL_METAGENE_3_PRECICTIVE_ICB_RESPONSE | 5.29e-06 | 211 | 118 | 8 | MM17081 | |
| Coexpression | MARTINEZ_RB1_TARGETS_DN | HLA-A HLA-B HLA-C HLA-E HLA-G HLA-H LANCL1 PTPRZ1 UPP1 CTTN MTX1 ATP2A2 CA6 | 5.46e-06 | 630 | 118 | 13 | MM1038 |
| Coexpression | ZEMEK_IMMUNE_CHECKPOINT_BLOCKADE_OVARIAN_CANCER_OVERLAP_UP | 5.50e-06 | 98 | 118 | 6 | MM460 | |
| Coexpression | ZEMEK_IMMUNE_CHECKPOINT_BLOCKADE_OVARIAN_CANCER_RENCA_UP | 6.18e-06 | 100 | 118 | 6 | MM458 | |
| Coexpression | HU_GENOTOXIN_ACTION_DIRECT_VS_INDIRECT_24HR | 6.43e-06 | 58 | 118 | 5 | MM661 | |
| Coexpression | PUJANA_BREAST_CANCER_LIT_INT_NETWORK | 6.55e-06 | 101 | 118 | 6 | M15356 | |
| Coexpression | CUI_DEVELOPING_HEART_C9_B_T_CELL | 6.72e-06 | 155 | 118 | 7 | M39306 | |
| Coexpression | TABULA_MURIS_SENIS_LUNG_BRONCHIAL_SMOOTH_MUSCLE_CELL_AGEING | 7.01e-06 | 156 | 118 | 7 | MM3763 | |
| Coexpression | TABULA_MURIS_SENIS_PANCREAS_PANCREATIC_DUCTAL_CELL_AGEING | 7.04e-06 | 291 | 118 | 9 | MM3820 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | DOCK1 STRN3 KDM5A WRN NUP98 MELK ZNF804A AHDC1 BRCA2 MID1 ITSN2 HELZ CRYBG3 SUCO SLC16A7 | 7.19e-06 | 856 | 118 | 15 | M4500 |
| Coexpression | GAUSSMANN_MLL_AF4_FUSION_TARGETS_A_DN | 7.34e-06 | 103 | 118 | 6 | MM476 | |
| Coexpression | TABULA_MURIS_SENIS_TONGUE_BASAL_CELL_OF_EPIDERMIS_AGEING | 7.62e-06 | 158 | 118 | 7 | MM3851 | |
| Coexpression | TABULA_MURIS_SENIS_MARROW_PROMONOCYTE_AGEING | 7.76e-06 | 104 | 118 | 6 | MM3812 | |
| Coexpression | TABULA_MURIS_SENIS_LUNG_FIBROBLAST_OF_LUNG_AGEING | 8.20e-06 | 224 | 118 | 8 | MM3767 | |
| Coexpression | ZENG_GU_ICB_CONTROL_METAGENE_25_PRECICTIVE_ICB_RESPONSE | 8.47e-06 | 225 | 118 | 8 | MM17079 | |
| Coexpression | KIM_LRRC3B_TARGETS | 9.77e-06 | 30 | 118 | 4 | M17363 | |
| Coexpression | TABULA_MURIS_SENIS_SPLEEN_B_CELL_AGEING | 1.13e-05 | 111 | 118 | 6 | MM3831 | |
| Coexpression | ZHANG_UTERUS_C8_NK_CELL | 1.14e-05 | 168 | 118 | 7 | MM16614 | |
| Coexpression | ZHANG_UTERUS_C9_DENDRITIC_CELL | 1.31e-05 | 114 | 118 | 6 | MM16615 | |
| Coexpression | TABULA_MURIS_SENIS_MARROW_HEMATOPOIETIC_PRECURSOR_CELL_AGEING | 1.31e-05 | 114 | 118 | 6 | MM3799 | |
| Coexpression | WNT_UP.V1_DN | 1.33e-05 | 172 | 118 | 7 | M2689 | |
| Coexpression | YU_MYC_TARGETS_DN | 1.41e-05 | 68 | 118 | 5 | MM632 | |
| Coexpression | LIN_NPAS4_TARGETS_UP | 1.98e-05 | 183 | 118 | 7 | MM767 | |
| Coexpression | TABULA_MURIS_SENIS_KIDNEY_KIDNEY_DISTAL_CONVOLUTED_TUBULE_EPITHELIAL_CELL_AGEING | 2.12e-05 | 124 | 118 | 6 | MM3726 | |
| Coexpression | SERVITJA_ISLET_HNF1A_TARGETS_UP | 2.12e-05 | 185 | 118 | 7 | MM1072 | |
| Coexpression | ZHANG_UTERUS_C5_MACROPHAGE | 2.27e-05 | 187 | 118 | 7 | MM16611 | |
| Coexpression | TABULA_MURIS_SENIS_HEART_AND_AORTA_CARDIOMYOCYTE_AGEING | 2.32e-05 | 126 | 118 | 6 | MM3711 | |
| Coexpression | TABULA_MURIS_SENIS_TRACHEA_FIBROBLAST_AGEING | 2.43e-05 | 127 | 118 | 6 | MM3856 | |
| Coexpression | SANA_RESPONSE_TO_IFNG_UP | 2.43e-05 | 76 | 118 | 5 | M4551 | |
| Coexpression | GHO_ATF5_TARGETS_UP | 2.46e-05 | 13 | 118 | 3 | M12008 | |
| Coexpression | TABULA_MURIS_SENIS_SPLEEN_CD4_POSITIVE_ALPHA_BETA_T_CELL_AGEING | 2.52e-05 | 190 | 118 | 7 | MM3832 | |
| Coexpression | GSE34205_RSV_VS_FLU_INF_INFANT_PBMC_DN | 2.98e-05 | 195 | 118 | 7 | M5142 | |
| Coexpression | MIKKELSEN_IPS_ICP_WITH_H3K4ME3_AND_H327ME3 | 3.02e-05 | 132 | 118 | 6 | MM841 | |
| Coexpression | TABULA_MURIS_SENIS_LIMB_MUSCLE_MESENCHYMAL_STEM_CELL_AGEING | 3.07e-05 | 196 | 118 | 7 | MM3746 | |
| Coexpression | TABULA_MURIS_SENIS_KIDNEY_KIDNEY_PROXIMAL_CONVOLUTED_TUBULE_EPITHELIAL_CELL_AGEING | 3.07e-05 | 196 | 118 | 7 | MM3730 | |
| Coexpression | GSE42021_TREG_PLN_VS_CD24LO_TREG_THYMUS_DN | 3.18e-05 | 197 | 118 | 7 | M9580 | |
| Coexpression | GSE42021_TREG_PLN_VS_TREG_PRECURSORS_THYMUS_DN | 3.50e-05 | 200 | 118 | 7 | M9570 | |
| Coexpression | GSE17721_CPG_VS_GARDIQUIMOD_12H_BMDC_UP | 3.50e-05 | 200 | 118 | 7 | M3894 | |
| Coexpression | GSE37533_PPARG1_FOXP3_VS_FOXP3_TRANSDUCED_CD4_TCELL_DN | 3.50e-05 | 200 | 118 | 7 | M8967 | |
| Coexpression | TABULA_MURIS_SENIS_LIMB_MUSCLE_SKELETAL_MUSCLE_SATELLITE_CELL_AGEING | 3.58e-05 | 136 | 118 | 6 | MM3747 | |
| Coexpression | ZHANG_UTERUS_C6_ENDOTHELIAL_PLVAP_HIGH_CELL | 3.73e-05 | 137 | 118 | 6 | MM16612 | |
| Coexpression | SANA_TNF_SIGNALING_UP | 3.73e-05 | 83 | 118 | 5 | M17466 | |
| Coexpression | JACKSON_DNMT1_TARGETS_UP | 3.95e-05 | 84 | 118 | 5 | M1604 | |
| Coexpression | YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_9 | 4.18e-05 | 85 | 118 | 5 | MM1279 | |
| Coexpression | LI_PBMC_MENOMUNE_A_C_Y_W_135_AGE_18_45YO_CORRELATED_WITH_ANTIBODY_RESPONSE_3DY_POSITIVE | 4.21e-05 | 43 | 118 | 4 | M41036 | |
| Coexpression | TABULA_MURIS_SENIS_LUNG_CD4_POSITIVE_ALPHA_BETA_T_CELL_AGEING | 4.55e-05 | 142 | 118 | 6 | MM3757 | |
| Coexpression | BOYLAN_MULTIPLE_MYELOMA_PCA1_UP | 4.74e-05 | 143 | 118 | 6 | MM1056 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW26-OPC_related|GW26 / Sample Type, Dataset, Time_group, and Cell type. | 8.77e-08 | 137 | 119 | 7 | 264d5e06c37d1a9ef7748091b67d2a5aa803096e | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW26-OPC_related-Oligodendrocyte/OPC|GW26 / Sample Type, Dataset, Time_group, and Cell type. | 8.77e-08 | 137 | 119 | 7 | 8ce463d1d74ac0ce80b812217d6bd76a788f14d2 | |
| ToppCell | PND10-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-ILC-ILC_prolif|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.66e-07 | 169 | 119 | 7 | 20fbf78382fb0ba9a63ab1aa0abc615476994ac5 | |
| ToppCell | CV-Severe-7|CV / Virus stimulation, Condition and Cluster | 4.82e-07 | 176 | 119 | 7 | 3de0c7d77210049e5616db21eed1490a17a5ec2d | |
| ToppCell | CV-Severe-7|Severe / Virus stimulation, Condition and Cluster | 5.01e-07 | 177 | 119 | 7 | 82fdd6185b368f54f03de389427cbe3071d21a99 | |
| ToppCell | Multiple_Sclerosis-Lymphocyte-T_NK-gdT|Multiple_Sclerosis / Disease, Lineage and Cell Type | 5.40e-07 | 179 | 119 | 7 | ab8d8104b38603ec7fbc5b35d7149e71ad57c43a | |
| ToppCell | 390C-Lymphocytic-NK_cells-NK_cell_C|390C / Donor, Lineage, Cell class and subclass (all cells) | 7.24e-07 | 187 | 119 | 7 | 1e8651e6c547384ace5a66b96c6b24a7f390a7ee | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.51e-07 | 188 | 119 | 7 | af740fa78542438fdff627ea1f74f4eee43316be | |
| ToppCell | T/NK_cells-CD56bright_NK_cell|World / Lineage and Cell class | 8.64e-07 | 192 | 119 | 7 | 528b5b790a0e8966d04ffbc83b049c93bac17537 | |
| ToppCell | Int-URO-Lymphocyte-T_NK-NK|Int-URO / Disease, Lineage and Cell Type | 8.95e-07 | 193 | 119 | 7 | 5c7942f630fc69374df34ee3602ad973b6ced17a | |
| ToppCell | 5'-Adult-LymphNode-Hematopoietic-T_cells-CD8_Tmem|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.27e-07 | 194 | 119 | 7 | 13c3674d601c8a7355ce869de1af6401938c0037 | |
| ToppCell | 3'_v3-bone_marrow-Lymphocytic_NK-NK_CD16|bone_marrow / Manually curated celltypes from each tissue | 9.27e-07 | 194 | 119 | 7 | 7773501e076d470158dbc1d7f10c67152b326eb7 | |
| ToppCell | systemic_lupus_erythematosus-managed-Lymphocytic_NK-natural_killer_cell-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 9.59e-07 | 195 | 119 | 7 | 72f42f0be53a2a61f61647118b4883e752d998a5 | |
| ToppCell | systemic_lupus_erythematosus-managed-Lymphocytic_NK-natural_killer_cell|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 9.59e-07 | 195 | 119 | 7 | 49a4f58aac168fc1838bd5d2b202135cd794c28b | |
| ToppCell | T/NK_cells-CD56dim_NK_cell|World / Lineage and Cell class | 9.59e-07 | 195 | 119 | 7 | 6124e87cb9061bf8918377fb4a79084079ddfc16 | |
| ToppCell | Healthy/Control-gd_T|Healthy/Control / Disease group and Cell class | 9.92e-07 | 196 | 119 | 7 | a6f9e55cd1cd7facadb3f508bded68023c997f3f | |
| ToppCell | Control-Lymphocyte-T_NK-NK|Control / Disease, Lineage and Cell Type | 9.92e-07 | 196 | 119 | 7 | 65838fddc920cdcecefe823f3ce1c95a7e50e82b | |
| ToppCell | 10x5'-Liver-Lymphocytic_NK-NK_CD16|Liver / Manually curated celltypes from each tissue | 9.92e-07 | 196 | 119 | 7 | e6d4853ccefbcd45a019cee595811f0474dcc036 | |
| ToppCell | tumor_Lung-T/NK_cells-NK|tumor_Lung / Location, Cell class and cell subclass | 9.92e-07 | 196 | 119 | 7 | 006e630f3d8033f45c6b7e9154d77000c7b0cb70 | |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_NK-NK_CD16|bone_marrow / Manually curated celltypes from each tissue | 9.92e-07 | 196 | 119 | 7 | a3b077e82b1550eb328c84b567b60179001f9a77 | |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_NK|bone_marrow / Manually curated celltypes from each tissue | 9.92e-07 | 196 | 119 | 7 | 1868ad537b7f04cdad0a0c8282aadbc4f257a722 | |
| ToppCell | systemic_lupus_erythematosus-managed-Lymphocytic_NK-NK_dim-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.03e-06 | 197 | 119 | 7 | 76304df40f87224f8e415677e3ee8fb183fe0c03 | |
| ToppCell | severe-unassigned|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.03e-06 | 197 | 119 | 7 | 70704b149b2820b8601d2495b7cd9cbe91eda262 | |
| ToppCell | Healthy_donor-gd_T|Healthy_donor / disease group, cell group and cell class (v2) | 1.06e-06 | 198 | 119 | 7 | 25158815287efbdd8f463baa755cbb874f3905f3 | |
| ToppCell | 390C-Lymphocytic-NK_cells-NK_cell_B|390C / Donor, Lineage, Cell class and subclass (all cells) | 1.06e-06 | 198 | 119 | 7 | 0dc4a564dcab8ac42f238f98ee1f2090b0dcffe6 | |
| ToppCell | Multiple_Sclerosis-Lymphocyte-T_NK-NK|Multiple_Sclerosis / Disease, Lineage and Cell Type | 1.06e-06 | 198 | 119 | 7 | d413020012977eb8da0a5641dd16d0b0a60bec38 | |
| ToppCell | 390C-Lymphocytic-NK_cells|390C / Donor, Lineage, Cell class and subclass (all cells) | 1.06e-06 | 198 | 119 | 7 | 872ddb2738c5e0375830bb0e5b2c50383bf58738 | |
| ToppCell | Healthy-NK|Healthy / disease group, cell group and cell class | 1.06e-06 | 198 | 119 | 7 | 3402f88ef2f05d61c16cbe61b996bcc8fd119261 | |
| ToppCell | Brain_organoid-organoid_Velasco_nature-6_mon-Radial_glial-oRG/Astroglia|6_mon / Sample Type, Dataset, Time_group, and Cell type. | 1.10e-06 | 199 | 119 | 7 | 0b96fad1be02f0fe7a608207770cc56a6b6b291e | |
| ToppCell | 390C-Lymphocytic-NK_cells-NK_cell_A|390C / Donor, Lineage, Cell class and subclass (all cells) | 1.10e-06 | 199 | 119 | 7 | f72db89fe7e511473fc849f8fadb8b6453ac8ae5 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-NK_cell-NK|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.10e-06 | 199 | 119 | 7 | 4820f5bcd7bc34c2ebf6a3422cc8eb383a3b5a4e | |
| ToppCell | 356C-Lymphocytic-NK_cells|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.10e-06 | 199 | 119 | 7 | 9c196c3d8260379d3c9711179e0a913ac9906438 | |
| ToppCell | distal-2-Endothelial-Capillary_Aerocyte|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.10e-06 | 199 | 119 | 7 | bf70c8bfe932bccac5014e55f82019c5148627e7 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-NK_cell|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.10e-06 | 199 | 119 | 7 | eb05ccae5187e4701bbbe6d714a6d2808fbcf306 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-NK_cell|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.10e-06 | 199 | 119 | 7 | 10c8729b779073c3bf808e85958d59147f0be5c5 | |
| ToppCell | 390C-Myeloid-Dendritic-cDC1|Dendritic / Donor, Lineage, Cell class and subclass (all cells) | 1.10e-06 | 199 | 119 | 7 | 60c658e0b709a6c413e9b014a26b453cada85619 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-NK_cell-NK-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.10e-06 | 199 | 119 | 7 | 867fd292f3879982422e840e087bfdb3b21a8715 | |
| ToppCell | lymphoid-T_cell-CD8+_Naive_T_cell|T_cell / Lineage, cell class and subclass | 1.10e-06 | 199 | 119 | 7 | 9ee40563e840a7fe97e7592539d42e19db438c64 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-NK_cell-NK-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.10e-06 | 199 | 119 | 7 | 5e9fe852a70546c9d235414a2c26ca3e67ba6eb9 | |
| ToppCell | Control-Lymphoid_T/NK-NK|Control / Disease group, lineage and cell class | 1.10e-06 | 199 | 119 | 7 | 94b2693a8378b9b2c58c6aebb2c6658d75b2e3de | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-NK_cell-NK|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.10e-06 | 199 | 119 | 7 | d2c9fb69e5ef75778a1652da293fcf8cfa7ecfcc | |
| ToppCell | COVID-19-COVID-19_Mild-Lymphocyte-T/NK-gd_T|COVID-19_Mild / Disease, condition lineage and cell class | 1.14e-06 | 200 | 119 | 7 | 6560753d3df2f87860b52052d4881aa45410f666 | |
| ToppCell | Brain_organoid-organoid_Velasco_nature-6_mon-Radial_glial|6_mon / Sample Type, Dataset, Time_group, and Cell type. | 1.14e-06 | 200 | 119 | 7 | 4477591efada4007bab1f689017e3ac285267d29 | |
| ToppCell | control|World / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.14e-06 | 200 | 119 | 7 | 97f36d2c197e03d93a1fc59949d77ae90f6e6a9a | |
| ToppCell | Control-Control-Lymphocyte-T/NK-NK|Control / Disease, condition lineage and cell class | 1.14e-06 | 200 | 119 | 7 | c64c27dbf4df42ca2ad2bd94b50fab87b4050ef3 | |
| ToppCell | MS-Multiple_Sclerosis-Lymphocyte-T/NK-gd_T|Multiple_Sclerosis / Disease, condition lineage and cell class | 1.14e-06 | 200 | 119 | 7 | 498a2632b111fbf2cd4d755e53698ac5573ba763 | |
| ToppCell | MS-Multiple_Sclerosis-Lymphocyte-T/NK-NK|Multiple_Sclerosis / Disease, condition lineage and cell class | 1.14e-06 | 200 | 119 | 7 | d7a611d88107d84b5995b353e8cf95c6a7eb79de | |
| ToppCell | Sepsis-Int-URO-Lymphocyte-T/NK-NK|Int-URO / Disease, condition lineage and cell class | 1.14e-06 | 200 | 119 | 7 | 3ae0f3dc4f6c9e0315155de80967134b2c1b3364 | |
| ToppCell | Sepsis-Leuk-UTI-Lymphocyte-T/NK-NK|Leuk-UTI / Disease, condition lineage and cell class | 1.14e-06 | 200 | 119 | 7 | bb37fed4872e71f413ae7c4aa12586fa31075334 | |
| ToppCell | BLOOD--(0)_NK_cell-(0)_NK_cells_(CD56dim-like)|(0)_NK_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 2.60e-06 | 145 | 119 | 6 | 6dd81d53d006fcc206a10969374a11c372f92133 | |
| ToppCell | tumor_Lymph_Node_/_Brain-B_lymphocytes-Undetermined|B_lymphocytes / Location, Cell class and cell subclass | 7.42e-06 | 174 | 119 | 6 | 390bd41ef114464f3db3e0cac4e67fe7571b4c23 | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway-Basal/Suprabasal|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 8.18e-06 | 177 | 119 | 6 | cbad1a23851151dbef01ea2af960e6f0944f838b | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_ADARB2_ADAM33|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.18e-06 | 177 | 119 | 6 | 1cb78133ac09ea3a3f5b5de07151033998406512 | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway-Basal/Suprabasal-Basal|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 8.18e-06 | 177 | 119 | 6 | ce86dfaeb74d995a19aea62f0fb15c4c0bb854b0 | |
| ToppCell | 356C-Lymphocytic-NK_cells-NK_cell_C|356C / Donor, Lineage, Cell class and subclass (all cells) | 8.45e-06 | 178 | 119 | 6 | 7203149864cc8d5ae25329fdbf15c6b73c3d3595 | |
| ToppCell | ASK428-Immune-NK_cell|ASK428 / Donor, Lineage and Cell class of Lung cells from Dropseq | 9.00e-06 | 180 | 119 | 6 | 857d09446e3e6737e83d0f10bfda2ba282d5ba75 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L2-5_VIP_TOX2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.29e-06 | 181 | 119 | 6 | 35bcdcd2651149692e5b150e887c0f450c81d2d4 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_ADARB2_ADAM33|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.29e-06 | 181 | 119 | 6 | 2f3d04d22d4ac016e61709ea5af3d48885c946c4 | |
| ToppCell | 356C-Lymphocytic-NK_cells-NK_cell_B2|356C / Donor, Lineage, Cell class and subclass (all cells) | 9.59e-06 | 182 | 119 | 6 | 52baef8173df0a55307c375674a37c2488066738 | |
| ToppCell | moderate-Epithelial-IRC-IFNG_responsive_cell|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 9.89e-06 | 183 | 119 | 6 | 4ba879552e2101a341f3224826d364ac64c72260 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.89e-06 | 183 | 119 | 6 | e3ffef2b57dc5b96466dccc9cd54ba326ccf378a | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_ADARB2_ADAM33|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.05e-05 | 185 | 119 | 6 | 487fa382232564f075960899d50afa0edae5d258 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L2-5_VIP_TOX2|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.05e-05 | 185 | 119 | 6 | caf4f57f2db9ff72a652c8573e16e7ab180ffc05 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Endothelial-lymphatic_endothelial-LEC4_(STAB2+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.05e-05 | 185 | 119 | 6 | fb84fcf7f51f53489bcb3962fa9cb483e48257ed | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Degenerative_Cortical_Intercalated_Cell_Type_A|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.05e-05 | 185 | 119 | 6 | 9438097e94219c1db922b8507e3a29106d32a923 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.08e-05 | 186 | 119 | 6 | d65fa6d8e8a195ea10cfde1499d096d6acf7a634 | |
| ToppCell | Smart-seq2-bone_marrow_(Smart-seq2)-lymphocytic-innate_lymphocytic-mature_NK_T_cell|bone_marrow_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.08e-05 | 186 | 119 | 6 | 1590fe72badffc79f1d390deb3207116ac2281bb | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Hematopoietic-B_cells-Pro-B|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.08e-05 | 186 | 119 | 6 | 4a5264e32ba004ed58dc4102d84e4bc4dbbe1440 | |
| ToppCell | Smart-seq2-bone_marrow_(Smart-seq2)-lymphocytic-innate_lymphocytic|bone_marrow_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.08e-05 | 186 | 119 | 6 | e84a0ba599935ca5e7af48e0fb0500e7ed195d55 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Endothelial-lymphatic_endothelial|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.08e-05 | 186 | 119 | 6 | 9d250d5ae7cf9129be05b41d70cb6c3a046c5f1e | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Hematopoietic-B_cells|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.08e-05 | 186 | 119 | 6 | 528ee88f6e27863c7bcdffd4416cbbd83fc65e9d | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Degenerative_Descending_Thin_Limb_Cell_Type_3|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.12e-05 | 187 | 119 | 6 | c31130fc2f9f882944b2ba366a034a03f051c4b9 | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_Invariant-Inducer-like-MAIT|lymph-node_spleen / Manually curated celltypes from each tissue | 1.19e-05 | 189 | 119 | 6 | afe3a4fe7c10eeeb7064129778d940269c9acbef | |
| ToppCell | Non-neuronal-Non-dividing-Radial_Glia-oRG/Astrocyte-7|World / Primary Cells by Cluster | 1.22e-05 | 190 | 119 | 6 | 8f1c490dd8e5f80382f5294fd1aa8cba4c3c647f | |
| ToppCell | PBMC-Severe-cDC_12|Severe / Compartment, Disease Groups and Clusters | 1.22e-05 | 190 | 119 | 6 | 84ee185939bdefb10705b621a70da27701eadcee | |
| ToppCell | wk_15-18-Hematologic_Lymphocytic-T_&_ILC-Th17|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.22e-05 | 190 | 119 | 6 | 3dcdd243aace89a8d080e9e181dffd2c56e770f0 | |
| ToppCell | Non-neuronal-Non-dividing-Radial_Glia-oRG/Astrocyte|World / Primary Cells by Cluster | 1.22e-05 | 190 | 119 | 6 | 7dbfd543398c63cbe1e68b54bcb5e2291f521935 | |
| ToppCell | Bac-SEP-Lymphocyte-T_NK-gdT|Bac-SEP / Disease, Lineage and Cell Type | 1.22e-05 | 190 | 119 | 6 | c7c5bc50082b2243cae8eb04784d03f14a739b3b | |
| ToppCell | 3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_T/NK-natural_killer_cell-NK_cells-NK_cells_L.1.3.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.26e-05 | 191 | 119 | 6 | 753deb090b7b78b4ef31604dbe5dbfc4dcf5184a | |
| ToppCell | 3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_T/NK-natural_killer_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.26e-05 | 191 | 119 | 6 | 355f5bcb220d917163833dead0050fc756c7b260 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_T/NK-natural_killer_cell-NK_cells|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.26e-05 | 191 | 119 | 6 | 337d7d7b89fe370e1fe005b9daad76c5dc3b8444 | |
| ToppCell | BLOOD--(1)_gd_T_cells| / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.26e-05 | 191 | 119 | 6 | 47ced00ed6fb47ddc6e9baa76186ea974720defd | |
| ToppCell | BLOOD--(1)_T_cell-(1)_gd_T_cells|(1)_T_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.26e-05 | 191 | 119 | 6 | c6914e2733de20ecd6d1d27786b9a03992d612e7 | |
| ToppCell | normal_Pleural_Fluid-T/NK_cells-NK|normal_Pleural_Fluid / Location, Cell class and cell subclass | 1.30e-05 | 192 | 119 | 6 | 59dd4f5ae9f1cca78adf60b71661092ef09e6641 | |
| ToppCell | COVID-19-lung-Secretory|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.30e-05 | 192 | 119 | 6 | 59261098ccb52306f837f632ebaea45b90ad30fe | |
| ToppCell | IPF-Epithelial-Basal|World / Disease state, Lineage and Cell class | 1.30e-05 | 192 | 119 | 6 | 9b91e0b162e6f3ce86dd15cc33c2e745d069581f | |
| ToppCell | CD8+_Memory_T_cell-CV-0|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster | 1.34e-05 | 193 | 119 | 6 | 995781d87a919c0380750878bafe584342bb83ad | |
| ToppCell | Non-neuronal-Non-dividing-Radial_Glia-oRG-34|World / Primary Cells by Cluster | 1.34e-05 | 193 | 119 | 6 | d55f792eb3db10452347681131e07e041348fd89 | |
| ToppCell | Bac-SEP-Lymphocyte-T_NK-NK|Bac-SEP / Disease, Lineage and Cell Type | 1.34e-05 | 193 | 119 | 6 | 8aa4ed2b11c6189d86e7de6bc68782fd156a37fb | |
| ToppCell | systemic_lupus_erythematosus-treated-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.34e-05 | 193 | 119 | 6 | fce4f805e53669acb4c188f87ac7d84408c0c218 | |
| ToppCell | systemic_lupus_erythematosus-treated-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.34e-05 | 193 | 119 | 6 | 6e1498153a7766c03fddbda1701dbf1596d21736 | |
| ToppCell | 3'_v3-bone_marrow-Lymphocytic_NK|bone_marrow / Manually curated celltypes from each tissue | 1.34e-05 | 193 | 119 | 6 | e790ab76c12f74a13936c231076f1e397283efb3 | |
| ToppCell | ICU-SEP-Lymphocyte-T_NK-NK|ICU-SEP / Disease, Lineage and Cell Type | 1.34e-05 | 193 | 119 | 6 | f110f86db305e41639087f5b1a2dff103c07adf0 | |
| ToppCell | metastatic_Lymph_Node-T/NK_cells-Cytotoxic_CD8+_T|metastatic_Lymph_Node / Location, Cell class and cell subclass | 1.38e-05 | 194 | 119 | 6 | 73c057b623829de793616d9d373a0018071d51d8 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.38e-05 | 194 | 119 | 6 | cb0422e7607dbd77204428b7e2c70dfe14a6ca11 | |
| ToppCell | 10x5'-blood-Lymphocytic_NK-NK_CD16|blood / Manually curated celltypes from each tissue | 1.38e-05 | 194 | 119 | 6 | c34a32f1cfe3e597cb0f91ba5bdd3e114e9f3d2e | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_T_CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 1.38e-05 | 194 | 119 | 6 | 68e9ad254fe94e2f59cf5c2b2ea3e1245cb85104 | |
| ToppCell | Leuk-UTI-Lymphocyte-T_NK-NK|Leuk-UTI / Disease, Lineage and Cell Type | 1.38e-05 | 194 | 119 | 6 | 36afc4e48d267be3b8aa1e33fad043bcd54c6bc5 | |
| ToppCell | IIF-Lymphocyte-T_NK-NK|IIF / Disease, Lineage and Cell Type | 1.42e-05 | 195 | 119 | 6 | 464ce05cb52f78aee22d3baa6641b37bd53aae16 | |
| ToppCell | (1)_T_CD8_CTL|World / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 1.42e-05 | 195 | 119 | 6 | f582b854e5a4c52764aad5abe4e28ea77a7445f7 | |
| Computational | Genes in the cancer module 293. | 1.10e-08 | 12 | 75 | 5 | MODULE_293 | |
| Computational | Genes in the cancer module 143. | 2.75e-08 | 14 | 75 | 5 | MODULE_143 | |
| Computational | Neighborhood of PTPRC | 4.18e-07 | 68 | 75 | 7 | GNF2_PTPRC | |
| Computational | Neighborhood of INPP5D | 4.68e-07 | 43 | 75 | 6 | GNF2_INPP5D | |
| Computational | Neighborhood of HLA-C | 1.76e-05 | 47 | 75 | 5 | GNF2_HLA_C | |
| Computational | Neighborhood of PTPN6 | 1.76e-05 | 47 | 75 | 5 | GNF2_PTPN6 | |
| Computational | Neighborhood of CD53 | 4.96e-05 | 58 | 75 | 5 | GNF2_CD53 | |
| Computational | Neighborhood of CD48 | 6.78e-05 | 32 | 75 | 4 | GNF2_CD48 | |
| Computational | Neighborhood of RAP1B | 1.09e-04 | 36 | 75 | 4 | GNF2_RAP1B | |
| Computational | Neighborhood of VAV1 | 1.09e-04 | 36 | 75 | 4 | GNF2_VAV1 | |
| Computational | Neighborhood of STAT6 | 2.18e-04 | 79 | 75 | 5 | GNF2_STAT6 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 3.95e-04 | 50 | 75 | 4 | GAVISH_3CA_MALIGNANT_METAPROGRAM_17_INTERFERON_MHC_II_1 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 3.95e-04 | 50 | 75 | 4 | GAVISH_3CA_METAPROGRAM_EPITHELIAL_INTERFERON_MHC | |
| Drug | Naphthols | 1.06e-08 | 6 | 119 | 4 | ctd:D009284 | |
| Drug | lavendustin C6 | 2.45e-08 | 7 | 119 | 4 | CID000126839 | |
| Drug | (-)-Cinchonidine [485-71-2]; Up 200; 13.6uM; MCF7; HT_HG-U133A | 1.01e-06 | 198 | 119 | 9 | 2772_UP | |
| Drug | 5-(alpha-methyl-4-bromobenzylamino)phosphonomethyl-1,4-dihydroquinoxaline-2,3-dione | 1.38e-06 | 5 | 119 | 3 | ctd:C498554 | |
| Drug | 2-Aminoadipic Acid | 1.38e-06 | 5 | 119 | 3 | ctd:D015074 | |
| Drug | (2S*,3R*)-1-(biphenyl-4-carbonyl)piperazine-2,3-dicarboxylic acid | 1.38e-06 | 5 | 119 | 3 | ctd:C491996 | |
| Drug | SDZ EAA 494 | 1.38e-06 | 5 | 119 | 3 | ctd:C065286 | |
| Drug | PMSD | 1.38e-06 | 5 | 119 | 3 | CID000083890 | |
| Drug | Meperidine | 2.75e-06 | 6 | 119 | 3 | DB00454 | |
| Drug | 1,5-(diethylamino)piperidine | 2.75e-06 | 6 | 119 | 3 | CID000004025 | |
| Drug | AC1L1BWR | 2.91e-06 | 76 | 119 | 6 | CID000001642 | |
| Drug | Tenocyclidine | 4.80e-06 | 7 | 119 | 3 | DB01520 | |
| Drug | tetrazol-5-yl)glycine | 4.80e-06 | 7 | 119 | 3 | CID000126383 | |
| Drug | 3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid | 4.80e-06 | 7 | 119 | 3 | ctd:C050592 | |
| Drug | homoquinolinate | 4.80e-06 | 7 | 119 | 3 | CID003080554 | |
| Drug | S)-piperazine-2-carboxylic acid | 4.80e-06 | 7 | 119 | 3 | CID001502069 | |
| Drug | alpha-naphthyl acetate | 6.29e-06 | 50 | 119 | 5 | CID000013247 | |
| Drug | xenon | 6.86e-06 | 88 | 119 | 6 | CID000023991 | |
| Drug | L-687,414 | 7.65e-06 | 8 | 119 | 3 | CID000125556 | |
| Drug | 6-chloroquinoxaline-2,3-diol | 7.65e-06 | 8 | 119 | 3 | CID000081143 | |
| Drug | ES-242-1 | 7.65e-06 | 8 | 119 | 3 | CID000131976 | |
| Drug | SDZ 220-581 | 7.65e-06 | 8 | 119 | 3 | CID000128019 | |
| Drug | 3alpha5betaHS | 7.65e-06 | 8 | 119 | 3 | CID000165024 | |
| Drug | neramexane | 7.65e-06 | 8 | 119 | 3 | CID006433106 | |
| Drug | piperazine-2,3-dicarboxylic acid | 7.65e-06 | 8 | 119 | 3 | CID000280973 | |
| Drug | magnesium sulfate | 7.65e-06 | 52 | 119 | 5 | CID000024083 | |
| Drug | sodium sulbactam | 1.11e-05 | 56 | 119 | 5 | CID000005316 | |
| Drug | Phenanthrenes | 1.14e-05 | 9 | 119 | 3 | ctd:D010616 | |
| Drug | tert-butyl acetate | 1.32e-05 | 58 | 119 | 5 | CID000010908 | |
| Drug | 3,5-dihydroxyphenylglycine | 1.56e-05 | 60 | 119 | 5 | CID000108001 | |
| Drug | NPC 12626 | 2.00e-05 | 31 | 119 | 4 | CID000108099 | |
| Drug | EAB 515 | 2.23e-05 | 11 | 119 | 3 | CID000159489 | |
| Drug | 5-phosphonopentanoic acid | 2.23e-05 | 11 | 119 | 3 | CID002773807 | |
| Drug | oxiracetam | 2.23e-05 | 11 | 119 | 3 | CID000004626 | |
| Drug | o-difluorobenzene | 2.23e-05 | 11 | 119 | 3 | CID000009706 | |
| Drug | CI-1041 | 2.96e-05 | 12 | 119 | 3 | CID000156328 | |
| Drug | tenocyclidine | 2.96e-05 | 12 | 119 | 3 | CID000062751 | |
| Drug | ONNO | 2.96e-05 | 12 | 119 | 3 | CID006857661 | |
| Drug | Succimer | STRN3 CTSF KDM5A G2E3 IDE ZNF804A TF EHD2 LIG4 BRCA2 MTX3 MID1 ITSN2 HELZ UPP1 KIF3C CLSPN ENO2 EIF2AK2 | 2.99e-05 | 1264 | 119 | 19 | ctd:D004113 |
| Drug | gacyclidine | 3.67e-05 | 36 | 119 | 4 | CID000176265 | |
| Drug | 1,10-diaminodecane | 3.83e-05 | 13 | 119 | 3 | CID000001317 | |
| Drug | Agmatine | 3.83e-05 | 13 | 119 | 3 | ctd:D000376 | |
| Drug | DHBT | 3.85e-05 | 119 | 119 | 6 | CID000001855 | |
| Drug | 2-methoxy-5-(2',3',4'-trimethoxyphenyl)tropone | 4.78e-05 | 320 | 119 | 9 | ctd:C030370 | |
| Drug | Magnetite Nanoparticles | STRN3 CTSF KDM5A G2E3 IDE ZNF804A TF EHD2 LIG4 BRCA2 MTX3 MID1 ITSN2 HELZ UPP1 KIF3C CLSPN ENO2 EIF2AK2 | 4.85e-05 | 1310 | 119 | 19 | ctd:D058185 |
| Drug | B-43 | 4.86e-05 | 14 | 119 | 3 | CID006603792 | |
| Drug | remacemide | 4.86e-05 | 14 | 119 | 3 | CID000060510 | |
| Drug | Prochlorperazine dimaleate [84-02-6]; Up 200; 6.6uM; MCF7; HT_HG-U133A | 4.90e-05 | 182 | 119 | 7 | 5010_UP | |
| Drug | D-Au | 5.24e-05 | 77 | 119 | 5 | CID000277822 | |
| Drug | benzimidazole-2-carboxylic acid | 5.61e-05 | 40 | 119 | 4 | CID000233240 | |
| Drug | AC1L1JND | 5.93e-05 | 79 | 119 | 5 | CID000005118 | |
| Drug | diethylenetriamine | 5.93e-05 | 79 | 119 | 5 | CID000008111 | |
| Drug | ACEA-1011 | 6.05e-05 | 15 | 119 | 3 | CID000127872 | |
| Drug | AC1L1FCN | 6.05e-05 | 15 | 119 | 3 | CID000003178 | |
| Drug | thiokynurenic acid | 6.05e-05 | 15 | 119 | 3 | CID003035667 | |
| Drug | AC1L3S1M | 6.19e-05 | 41 | 119 | 4 | CID000121071 | |
| Drug | haloperidol; Down 200; 10uM; HL60; HT_HG-U133A | 7.33e-05 | 194 | 119 | 7 | 1185_DN | |
| Drug | argiopine | 7.42e-05 | 16 | 119 | 3 | CID000122294 | |
| Drug | metaphit | 7.42e-05 | 16 | 119 | 3 | CID000114745 | |
| Drug | 3,4,7,8-tetrahydroquinoline | 7.42e-05 | 16 | 119 | 3 | CID000094356 | |
| Drug | LY233536 | 7.42e-05 | 16 | 119 | 3 | CID000126239 | |
| Drug | Streptomycin sulfate [3810-74-0]; Up 200; 2.8uM; HL60; HG-U133A | 8.07e-05 | 197 | 119 | 7 | 1578_UP | |
| Drug | N-succinylphenylglycine | 8.10e-05 | 3 | 119 | 2 | CID000448582 | |
| Drug | conotoxin GV | 8.10e-05 | 3 | 119 | 2 | ctd:C055407 | |
| Drug | AC1MOUJL | 8.10e-05 | 3 | 119 | 2 | CID003400924 | |
| Drug | Cefadroxil | 8.10e-05 | 3 | 119 | 2 | ctd:D002434 | |
| Drug | C03356 | 8.10e-05 | 3 | 119 | 2 | CID000439988 | |
| Drug | 3-bromo-2-(bromomethyl)propionic acid | 8.10e-05 | 3 | 119 | 2 | CID000318915 | |
| Drug | C04309 | 8.10e-05 | 3 | 119 | 2 | CID000440293 | |
| Drug | 2,3-diketo-1-phosphohexane | 8.10e-05 | 3 | 119 | 2 | CID000192519 | |
| Drug | 2-PE | 8.97e-05 | 17 | 119 | 3 | CID000004867 | |
| Drug | PRE-084 | 8.97e-05 | 17 | 119 | 3 | CID000126402 | |
| Drug | 7-Cl-Thio-Kyna | 8.97e-05 | 17 | 119 | 3 | CID003035668 | |
| Drug | ADCI | 8.97e-05 | 17 | 119 | 3 | CID000130099 | |
| Drug | AC1L1AV8 | 9.77e-05 | 46 | 119 | 4 | CID000001163 | |
| Drug | Minocycline | 9.93e-05 | 88 | 119 | 5 | ctd:D008911 | |
| Drug | 3-hydroxyglutaric acid | 1.07e-04 | 18 | 119 | 3 | CID000181976 | |
| Drug | MNQX | 1.07e-04 | 18 | 119 | 3 | CID000130818 | |
| Drug | Dantrolene-13C3 | 1.16e-04 | 145 | 119 | 6 | CID000002951 | |
| Drug | DNA-PK inhibitor | 1.27e-04 | 19 | 119 | 3 | CID000088505 | |
| Drug | arcaine | 1.27e-04 | 19 | 119 | 3 | CID000002227 | |
| Drug | C22H28N2O4 | 1.27e-04 | 19 | 119 | 3 | CID000065570 | |
| Drug | AC1L1FA8 | 1.36e-04 | 50 | 119 | 4 | CID000003150 | |
| Drug | BMS-186282 | 1.43e-04 | 95 | 119 | 5 | CID000002416 | |
| Drug | IDRA 21 | 1.49e-04 | 20 | 119 | 3 | CID000003688 | |
| Drug | ginsenoside Rc | 1.49e-04 | 20 | 119 | 3 | CID000100018 | |
| Drug | VAI2 | 1.57e-04 | 97 | 119 | 5 | CID003474204 | |
| Drug | dimethyl chlorophosphate | 1.61e-04 | 4 | 119 | 2 | CID000101863 | |
| Drug | PA-J | 1.61e-04 | 4 | 119 | 2 | CID000447261 | |
| Drug | [2-(oxidoamino)-2-oxoethyl]phosphonic acid | 1.61e-04 | 4 | 119 | 2 | CID011969443 | |
| Drug | 3-aminoenolpyruvate-2-phosphate | 1.61e-04 | 4 | 119 | 2 | CID003037152 | |
| Drug | Poly C | 1.61e-04 | 4 | 119 | 2 | ctd:D011066 | |
| Drug | 2-ptz | 1.61e-04 | 4 | 119 | 2 | CID000445375 | |
| Drug | tricyclohexylammonium | 1.61e-04 | 4 | 119 | 2 | CID000226271 | |
| Drug | Celecoxib | 1.63e-04 | 376 | 119 | 9 | ctd:D000068579 | |
| Drug | 1,2-dimethylethylene | 1.70e-04 | 53 | 119 | 4 | CID000012220 | |
| Drug | N-Ac-D-E | 1.70e-04 | 53 | 119 | 4 | CID000005255 | |
| Drug | magnesium fluoride | 1.70e-04 | 53 | 119 | 4 | CID000024546 | |
| Drug | Ketorolac | 1.73e-04 | 21 | 119 | 3 | ctd:D020910 | |
| Drug | carbetapentane | 1.73e-04 | 21 | 119 | 3 | CID000002562 | |
| Disease | graft-versus-host disease (implicated_via_orthology) | 1.57e-11 | 7 | 113 | 5 | DOID:0081267 (implicated_via_orthology) | |
| Disease | Schizophrenia | HLA-A HLA-B HLA-C ABCA13 HLA-E GRIN2A IDE GRIN2C GRIN2D DBN1 ZNF804A TF PTPRZ1 GNAO1 ATP2A2 ENO2 | 2.67e-07 | 883 | 113 | 16 | C0036341 |
| Disease | hepatitis B virus infection | 7.56e-07 | 19 | 113 | 4 | EFO_0004197 | |
| Disease | autism spectrum disorder, schizophrenia | 4.91e-06 | 327 | 113 | 9 | EFO_0003756, MONDO_0005090 | |
| Disease | beta-2 microglobulin measurement | 8.82e-06 | 11 | 113 | 3 | EFO_0005197 | |
| Disease | Parapsoriasis en Plaques | 1.45e-05 | 2 | 113 | 2 | C0162442 | |
| Disease | – | 1.45e-05 | 2 | 113 | 2 | 608579 | |
| Disease | Erythroderma, Maculopapular | 1.45e-05 | 2 | 113 | 2 | C0014799 | |
| Disease | Parakeratosis Variegata | 1.45e-05 | 2 | 113 | 2 | C0030437 | |
| Disease | Parapsoriasis | 1.45e-05 | 2 | 113 | 2 | C0030491 | |
| Disease | Susceptibility to severe cutaneous adverse reaction | 1.45e-05 | 2 | 113 | 2 | cv:C1840548 | |
| Disease | Carbamazepine response | 1.45e-05 | 2 | 113 | 2 | cv:CN077964 | |
| Disease | Bipolar Disorder | SLC12A6 ABCA13 HLA-E HLA-G NAPG GRIN2A DBN1 ZNF804A BRCA2 AFG1L | 1.56e-05 | 477 | 113 | 10 | C0005586 |
| Disease | basophil count | ZBTB16 HLA-A HLA-B HLA-C HLA-G HLA-H YWHAB LRRC25 PRKDC GNAO1 | 1.74e-05 | 483 | 113 | 10 | EFO_0005090 |
| Disease | susceptibility to Mycobacterium tuberculosis infection measurement | 2.05e-05 | 86 | 113 | 5 | EFO_0008407 | |
| Disease | uric acid measurement | PIGN CEL CCDC18 TTC27 ADGRV1 AR SIK2 GNAO1 GNAT2 MTX1 ATP2A2 | 2.33e-05 | 610 | 113 | 11 | EFO_0004761 |
| Disease | neutrophil percentage of granulocytes | 2.89e-05 | 228 | 113 | 7 | EFO_0007994 | |
| Disease | developmental disorder of mental health (implicated_via_orthology) | 3.78e-05 | 49 | 113 | 4 | DOID:0060037 (implicated_via_orthology) | |
| Disease | glucose homeostasis measurement, acute insulin response measurement | 4.28e-05 | 18 | 113 | 3 | EFO_0006831, EFO_0006896 | |
| Disease | Brody myopathy (implicated_via_orthology) | 4.35e-05 | 3 | 113 | 2 | DOID:0050692 (implicated_via_orthology) | |
| Disease | complement C4 measurement | 4.79e-05 | 52 | 113 | 4 | EFO_0004984 | |
| Disease | lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma | 4.79e-05 | 52 | 113 | 4 | EFO_0000305, EFO_0000571, EFO_0000708, EFO_0001071, EFO_0001075, EFO_0001663, EFO_1000650, EFO_1001515, EFO_1001516, MONDO_0005575 | |
| Disease | Severe Combined Immunodeficiency | 5.94e-05 | 20 | 113 | 3 | C0085110 | |
| Disease | occupational asthma (is_implicated_in) | 8.68e-05 | 4 | 113 | 2 | DOID:0080820 (is_implicated_in) | |
| Disease | Stevens-Johnson syndrome (is_implicated_in) | 8.68e-05 | 4 | 113 | 2 | DOID:0050426 (is_implicated_in) | |
| Disease | prostate cancer (is_implicated_in) | 8.97e-05 | 117 | 113 | 5 | DOID:10283 (is_implicated_in) | |
| Disease | chronic hepatitis B virus infection | 1.04e-04 | 24 | 113 | 3 | EFO_0004239 | |
| Disease | serum IgE measurement | 1.09e-04 | 64 | 113 | 4 | EFO_0004579 | |
| Disease | cognitive function measurement | CEL HLA-B WRN GRIN2A DBN1 ZNF804A JAK1 IL1RAPL1 ITSN2 GCC1 KIF3C GNAO1 SPAG16 CDH9 ARHGAP21 AFG1L | 1.15e-04 | 1434 | 113 | 16 | EFO_0008354 |
| Disease | susceptibility to cold sores measurement | 1.15e-04 | 65 | 113 | 4 | EFO_0008402 | |
| Disease | Structural Clinical Interview for DSM-III | 1.44e-04 | 5 | 113 | 2 | C0700216 | |
| Disease | allergic asthma (is_implicated_in) | 1.44e-04 | 5 | 113 | 2 | DOID:9415 (is_implicated_in) | |
| Disease | attention deficit hyperactivity disorder, autism spectrum disorder, intelligence | 1.52e-04 | 398 | 113 | 8 | EFO_0003756, EFO_0003888, EFO_0004337 | |
| Disease | Malignant Glioma | 1.54e-04 | 70 | 113 | 4 | C0555198 | |
| Disease | mixed gliomas | 1.54e-04 | 70 | 113 | 4 | C0259783 | |
| Disease | neutrophil count, eosinophil count | 1.75e-04 | 213 | 113 | 6 | EFO_0004833, EFO_0004842 | |
| Disease | Drug-Induced Stevens Johnson Syndrome | 1.86e-04 | 29 | 113 | 3 | C1274933 | |
| Disease | Mycoplasma-Induced Stevens-Johnson Syndrome | 1.86e-04 | 29 | 113 | 3 | C3658301 | |
| Disease | Stevens-Johnson Syndrome Toxic Epidermal Necrolysis Spectrum | 1.86e-04 | 29 | 113 | 3 | C3658302 | |
| Disease | Toxic Epidermal Necrolysis | 1.86e-04 | 29 | 113 | 3 | C0014518 | |
| Disease | Stevens-Johnson Syndrome | 2.06e-04 | 30 | 113 | 3 | C0038325 | |
| Disease | neutrophil count, basophil count | 2.30e-04 | 224 | 113 | 6 | EFO_0004833, EFO_0005090 | |
| Disease | Takayasu arteritis | 2.69e-04 | 148 | 113 | 5 | EFO_1001857 | |
| Disease | susceptibility to shingles measurement | 2.70e-04 | 81 | 113 | 4 | EFO_0008401 | |
| Disease | eosinophil percentage of granulocytes | 2.91e-04 | 234 | 113 | 6 | EFO_0007996 | |
| Disease | psoriatic arthritis | 3.55e-04 | 87 | 113 | 4 | EFO_0003778 | |
| Disease | Glioma | 3.55e-04 | 87 | 113 | 4 | C0017638 | |
| Disease | endometrial cancer (is_implicated_in) | 3.56e-04 | 36 | 113 | 3 | DOID:1380 (is_implicated_in) | |
| Disease | cognitive disorder (biomarker_via_orthology) | 4.01e-04 | 8 | 113 | 2 | DOID:1561 (biomarker_via_orthology) | |
| Disease | McCune Albright syndrome (implicated_via_orthology) | 4.01e-04 | 8 | 113 | 2 | DOID:1858 (implicated_via_orthology) | |
| Disease | Malignant tumor of prostate | 5.14e-04 | 9 | 113 | 2 | cv:C0376358 | |
| Disease | Autistic Disorder | 5.19e-04 | 261 | 113 | 6 | C0004352 | |
| Disease | Combined immunodeficiency | 5.24e-04 | 41 | 113 | 3 | C0494261 | |
| Disease | eosinophil count | ZBTB7C CEL HLA-A HLA-B HLA-C CCDC18 HLA-G CACHD1 ZAP70 JAK1 SLC9C1 SIK2 PRKDC GNAO1 ATP2A3 | 5.59e-04 | 1488 | 113 | 15 | EFO_0004842 |
| Disease | human papilloma virus infection, oral cavity cancer | 5.63e-04 | 42 | 113 | 3 | EFO_0001668, EFO_0005570 | |
| Disease | neutrophil percentage of leukocytes | 5.77e-04 | 610 | 113 | 9 | EFO_0007990 | |
| Disease | eosinophil percentage of leukocytes | 6.01e-04 | 746 | 113 | 10 | EFO_0007991 | |
| Disease | cervical carcinoma, Cervical Intraepithelial Neoplasia Grade 2/3 | 6.41e-04 | 10 | 113 | 2 | EFO_0001061, EFO_1000166 | |
| Disease | visceral:gluteofemoral adipose tissue ratio measurement | 6.90e-04 | 45 | 113 | 3 | EFO_0803319 | |
| Disease | cervical carcinoma | 6.93e-04 | 182 | 113 | 5 | EFO_0001061 | |
| Disease | type 2 diabetes mellitus (implicated_via_orthology) | 7.24e-04 | 105 | 113 | 4 | DOID:9352 (implicated_via_orthology) | |
| Disease | oropharynx cancer | 7.36e-04 | 46 | 113 | 3 | EFO_1001931 | |
| Disease | T-cell acute lymphoblastic leukemia (is_implicated_in) | 7.82e-04 | 11 | 113 | 2 | DOID:5603 (is_implicated_in) | |
| Disease | basal cell carcinoma | 8.21e-04 | 189 | 113 | 5 | EFO_0004193 | |
| Disease | cesarean section, intelligence | 9.36e-04 | 12 | 113 | 2 | EFO_0004337, EFO_0009636 | |
| Disease | Charcot-Marie-Tooth disease (is_implicated_in) | 9.36e-04 | 12 | 113 | 2 | DOID:10595 (is_implicated_in) | |
| Disease | R-6-hydroxywarfarin measurement | 9.84e-04 | 114 | 113 | 4 | EFO_0803327 | |
| Disease | mean corpuscular hemoglobin concentration | ZBTB16 HLA-B BCCIP NEB TF CDKAL1 LRRC25 KIF3C PRKDC CLSPN ENO2 ARHGAP21 | 1.10e-03 | 1105 | 113 | 12 | EFO_0004528 |
| Disease | glycoprotein measurement | 1.15e-03 | 119 | 113 | 4 | EFO_0004555 | |
| Disease | diffuse large B-cell lymphoma | 1.28e-03 | 14 | 113 | 2 | EFO_0000403 | |
| Disease | cholesteryl ester measurement, low density lipoprotein cholesterol measurement | 1.43e-03 | 126 | 113 | 4 | EFO_0004611, EFO_0010351 | |
| Disease | response to efavirenz, virologic response measurement | 1.45e-03 | 58 | 113 | 3 | EFO_0006904, EFO_0006906 | |
| Disease | liver neoplasm | 1.48e-03 | 15 | 113 | 2 | EFO_1001513 | |
| Disease | killer cell immunoglobulin-like receptor 2DS2 measurement | 1.48e-03 | 15 | 113 | 2 | EFO_0801746 | |
| Disease | creatinine measurement | 1.54e-03 | 995 | 113 | 11 | EFO_0004518 | |
| Disease | Sjogren syndrome | 1.60e-03 | 60 | 113 | 3 | EFO_0000699 | |
| Disease | verbal-numerical reasoning measurement | 1.64e-03 | 131 | 113 | 4 | EFO_0008394 | |
| Disease | psoriasis vulgaris | 1.67e-03 | 61 | 113 | 3 | EFO_1001494 | |
| Disease | mosquito bite reaction itch intensity measurement, mosquito bite reaction size measurement | 1.68e-03 | 328 | 113 | 6 | EFO_0008377, EFO_0008378 | |
| Disease | amyloid-beta measurement, Alzheimer's disease biomarker measurement | 1.68e-03 | 16 | 113 | 2 | EFO_0005194, EFO_0006514 | |
| Disease | non-high density lipoprotein cholesterol measurement | 1.71e-03 | 713 | 113 | 9 | EFO_0005689 | |
| Disease | response to interferon-beta, anti-drug antibody measurement | 1.90e-03 | 17 | 113 | 2 | EFO_0010559, GO_0035456 | |
| Disease | susceptibility to hepatitis B infection measurement | 1.92e-03 | 64 | 113 | 3 | EFO_0008405 | |
| Disease | hip circumference | 1.96e-03 | 338 | 113 | 6 | EFO_0005093 | |
| Disease | cytokine measurement | 2.02e-03 | 461 | 113 | 7 | EFO_0004873 | |
| Disease | sclerosing cholangitis | 2.10e-03 | 66 | 113 | 3 | EFO_0004268 | |
| Disease | tropical spastic paraparesis | 2.14e-03 | 18 | 113 | 2 | EFO_0007527 | |
| Disease | diabetes mellitus | 2.29e-03 | 68 | 113 | 3 | EFO_0000400 | |
| Disease | cholesterol:total lipids ratio, low density lipoprotein cholesterol measurement | 2.32e-03 | 144 | 113 | 4 | EFO_0004611, EFO_0020943 | |
| Disease | ankylosing spondylitis (is_implicated_in) | 2.38e-03 | 19 | 113 | 2 | DOID:7147 (is_implicated_in) | |
| Disease | glomerulonephritis (is_marker_for) | 2.38e-03 | 19 | 113 | 2 | DOID:2921 (is_marker_for) | |
| Disease | DiGeorge syndrome (implicated_via_orthology) | 2.38e-03 | 19 | 113 | 2 | DOID:11198 (implicated_via_orthology) | |
| Disease | Omenn Syndrome | 2.38e-03 | 19 | 113 | 2 | C2700553 | |
| Disease | angiopoietin-1 receptor measurement | 2.38e-03 | 19 | 113 | 2 | EFO_0010600 | |
| Disease | basophil count, eosinophil count | 2.39e-03 | 241 | 113 | 5 | EFO_0004842, EFO_0005090 | |
| Disease | cognitive function measurement, self reported educational attainment | 2.50e-03 | 355 | 113 | 6 | EFO_0004784, EFO_0008354 | |
| Disease | lung carcinoma | 2.60e-03 | 482 | 113 | 7 | EFO_0001071 | |
| Disease | Adenocarcinoma of prostate | 2.64e-03 | 20 | 113 | 2 | C0007112 | |
| Disease | nasopharyngeal neoplasm | 2.75e-03 | 151 | 113 | 4 | EFO_0004252 | |
| Disease | juvenile idiopathic arthritis | 2.91e-03 | 74 | 113 | 3 | EFO_0002609 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| DYFRYLSEVASGDNK | 126 | P31946 | |
| KADILYFDGDDAISY | 171 | P78357 | |
| ETDYSDKGYNLAFVS | 1976 | Q68DQ2 | |
| SKYDEIFYNLAPADG | 451 | Q9NZN4 | |
| INESKGDAIYSAVYD | 901 | Q8WXG9 | |
| AGKLYYLTSEADVEA | 291 | Q8WV93 | |
| DSLASYTFLIDDKGY | 501 | Q5VU97 | |
| KSDYEGDLNKSLYFD | 2786 | Q86UQ4 | |
| VYGKLAEDYASEAEN | 216 | Q8N2N9 | |
| YAADANDSKAEYSDV | 601 | Q5TGY3 | |
| INLYANAADIDYIAG | 321 | P19835 | |
| YKSYDIAQDAPDGLA | 146 | P23280 | |
| VAASEFYRDGKYDLD | 246 | P09104 | |
| NDSALDYNEAKGVYE | 421 | Q93084 | |
| KGDSFAYIQYESLDA | 451 | Q8NDT2 | |
| YAKYADRISANDAIA | 431 | Q8IUH3 | |
| YDYAANNEDELSFSK | 1136 | Q9NZM3 | |
| DASSLEYLFAQGQYD | 151 | P23458 | |
| AYDGKDYIALNEDLR | 141 | P01893 | |
| TASDKNYVAGLIDYD | 361 | Q14680 | |
| YSAYIDNFLNAKDAV | 1161 | Q96PE2 | |
| RDVYGKLAEDYASEA | 226 | Q5JPF3 | |
| AYDGKDYLALNEDLR | 141 | P17693 | |
| DYELSAKQGADTLAY | 81 | Q5HYI7 | |
| GSYAVQAELGDYDAE | 216 | Q9H4G0 | |
| SDAIINENYDYLKGF | 1656 | P52948 | |
| NENYDYLKGFLEDLA | 1661 | P52948 | |
| QFAYDGKDYLTLNED | 136 | P13747 | |
| ADYNKSLAEGYFDAA | 11 | O43813 | |
| NNDGYIDYAEFAKSL | 131 | Q8NI22 | |
| DLASFDEDLADYLYK | 76 | P33992 | |
| AEAALAYLYSGDAQQ | 56 | Q6PRD1 | |
| DNDFYINYKDIDLAS | 266 | Q8N386 | |
| DYITEKLYNAFLAGS | 251 | Q9Y231 | |
| FEAYSLSDNDYDGIK | 61 | Q9P287 | |
| NEGDAYYLLKDFALT | 1661 | Q8IY21 | |
| KAYAYADEDEGRPAN | 786 | Q86SJ6 | |
| DAVYDASSKQADLYD | 61 | O14782 | |
| AYDGKDYIALNEDLR | 141 | P10321 | |
| YAYLALNSEARAGDK | 296 | Q9Y4D7 | |
| EELDGDNKDYDAYLS | 396 | Q9NZN1 | |
| YAKDQGIDEYSAAFL | 271 | O60669 | |
| SLYKSGALDEAAAYQ | 346 | P10275 | |
| LYTYEDGSDDLKLAA | 31 | Q16643 | |
| DGKLTDYINANYVDG | 1776 | P23471 | |
| EDLDYGFLSNYKLLN | 1021 | P42694 | |
| AYDGKDYIALNEDLR | 141 | P01889 | |
| NYAYLEQLESLSAKG | 1016 | P29375 | |
| ATYYFKDQSAAEIGD | 186 | Q13093 | |
| SGLAEDQDKVYSLFY | 266 | Q9NZP5 | |
| ADEYSLYAKNENTGV | 76 | Q8NHR9 | |
| LNSQALKENLYYEAG | 436 | Q7L622 | |
| ENYAAEYANALEKGL | 136 | Q1HG44 | |
| NDSALDYNEAKGVYE | 421 | P16615 | |
| ADGEKATALYYQQEL | 471 | Q96CN9 | |
| ANGDYEKAAEFYKEA | 496 | Q13099 | |
| GDEDSAAALGLLYDY | 56 | Q6ISB3 | |
| AFYNYDARGADELSL | 16 | Q14185 | |
| YGDSYFIDTDLNQLK | 761 | P49917 | |
| LIAYASTADGYSADL | 211 | Q14574 | |
| EAVKNAADPAYLEGY | 2906 | P51587 | |
| SSQDYGKEVDLYALG | 461 | P19525 | |
| SDYYNKDNEEESLLA | 6 | Q5T9S5 | |
| QLAAYGYKITENASD | 86 | Q5VV42 | |
| YKLFYEAAQELLDGN | 586 | Q8TF46 | |
| LYIANVEASDKGNYS | 196 | Q12860 | |
| KNLGGLETEDDYSYQ | 346 | Q9UBX1 | |
| AYDGKDYIALNEDLR | 141 | P04439 | |
| DANYDGKDYDPVAAR | 116 | Q15691 | |
| KLAREYALLGNYDSA | 11 | O75449 | |
| KDSLNEYAYAAELAG | 601 | P14735 | |
| VAASEFYRNGKYDLD | 246 | P13929 | |
| NYEEGDEYFDKNLAL | 121 | Q9UHW9 | |
| ADDANYGNSAKVVYS | 186 | Q9ULB4 | |
| DSYLFDLDNKDGEVY | 1171 | Q9H9B1 | |
| LSLARANSGDQDYKY | 166 | B1AKI9 | |
| YAYKLGENNAELNAL | 316 | P15086 | |
| IYYFAKQIGAEDLSD | 136 | Q3ZCT8 | |
| EKYNADYDLSARQGA | 226 | Q13505 | |
| LLYKTDYSNDFDSEG | 711 | A6NES4 | |
| DKQAYLEAAYAAGVR | 231 | Q16831 | |
| NDADYSYDLPANKDA | 451 | Q13033 | |
| ALLLAYSDLYFGSDK | 381 | Q4G0N8 | |
| QKAAGDVDIGDAAYY | 211 | P09758 | |
| AYFAYKDGDIDSSLV | 486 | Q5TEA6 | |
| LDKDDYAYNAVAQDV | 201 | Q15573 | |
| DSAKYYLDSLDRIGA | 151 | P09471 | |
| YDDAGNYIKSQFLDL | 296 | P19087 | |
| DLEDFENNTAYAKYA | 131 | P55083 | |
| TEYAKNGEIFDYLAN | 96 | Q9H0K1 | |
| AAGYYQLALAAAVDL | 1256 | Q8TE82 | |
| KGASYSDDIYKEDFN | 926 | Q8IZU2 | |
| TEDQKLYAATDAYAG | 206 | Q14191 | |
| SLGEYEKAACYAANS | 306 | Q8NHS4 | |
| DEYTKGYLDQASGSA | 626 | Q03692 | |
| YDSAEEENKENLYAG | 81 | Q9HAW4 | |
| GLSKALGADDSYYTA | 481 | P43403 | |
| YAYTATLQAKAEDLD | 86 | Q05516 | |
| ADAVTLDAGLVYDAY | 76 | P02787 | |
| YDSAASEYGKAAVAF | 31 | Q99747 | |
| DLEYYINLVDKAAAG | 491 | Q96MW7 | |
| YEDAASFKAELSYRG | 421 | Q14247 | |
| TAVALYDYQAAGDDE | 496 | Q14247 | |
| TLKDNLGAGYAEDYT | 246 | Q9BXP2 | |
| DTADAVAAEGAYYLE | 31 | Q8N0X2 | |
| ILLDYDNGSIAFYDA | 606 | O15344 | |
| YLGATCAYDAAKVLA | 1046 | Q8TEQ6 | |
| YSGYDIEDALVLNKA | 746 | Q9NW08 | |
| SAALKADDDYKDYGV | 196 | O75764 | |
| DFYAELQNSTDLGYA | 886 | Q9UBS9 | |
| TYSYDAKREDFGAQD | 156 | O95427 | |
| ARSDYSEAAKQYDEA | 2961 | P78527 | |
| KAENDYGAYLNFLSA | 326 | A1YPR0 | |
| YLALEDYQGSAKAFQ | 571 | Q6P3X3 | |
| DVTALAYSQDAYLKG | 171 | Q5T5U3 | |
| EAENSYTENAGKYLL | 621 | Q7Z570 | |
| AYGDSLDKQNEASYL | 211 | Q8NFW9 | |
| DAFIYDAAVLNYKAG | 726 | Q12879 | |
| AYDLQSDALYKADLE | 3861 | P20929 | |
| GKLDAFIYDAAVLNY | 721 | Q14957 | |
| GKLDAFIYDAAVLNY | 751 | O15399 |